PATH: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization: PATH (EIN 91-1157127)
Tax period: 2017-01-01 to 2017-12-31
Filed: 2018-11-12
IRS object ID: 201803169349303250
Schema version: 2017v2.3
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2018-11-12T13:06:08-06:00	ReturnTs
Tax Period End	2017-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	521392008	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	GELMAN ROSENBERG & FREEDMAN	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	4550 MONTGOMERY AVE SUITE 650N	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	208142930	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2017-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	911157127	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	PATH	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	PATH	BusinessNameControlTxt
Phone	2062853500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2201 WESTLAKE AVENUE NO 200	AddressLine1Txt
City	SEATTLE	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98121	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	OLIVIA D POLIUS	PersonNm
Person Title	CHIEF FINANCIAL OFFICER	PersonTitleTxt
Phone	2062853500	PhoneNum
Signature	2018-11-12	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Phone	3019519090	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	75.103.231.202	IPv4AddressTxt

Field	Value	IRS element (for citing)
IP	2018-11-12	IPDt
IP Tm	14:06:02	IPTm
IP Timezone	ES	IPTimezoneCd
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	4FA38BE9C690C82C721A5060F87FC7588CB81F81	AtSubmissionCreationDeviceId
At Submission Filing Device Id	92DED79A3FD2BE8CA1FF310A7D004DEBEF0EEB01	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2017	TaxYr
Build TS	2019-02-21 02:37:17Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	STEPHEN B DAVIS	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2201 WESTLAKE AVENUE NO 200	AddressLine1Txt
City	SEATTLE	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98121	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$461,908,374	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.PATH.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1981	FormationYr
Legal Domicile State	WA	LegalDomicileStateCd
Activity Or Mission	SEE PART III, LINE 1.	ActivityOrMissionDesc
Voting Members Governing Body	13	VotingMembersGoverningBodyCnt
Voting Members Independent	13	VotingMembersIndependentCnt
Total Employee	888	TotalEmployeeCnt
Total Volunteers	0	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$298,315,988	PYContributionsGrantsAmt
CY Contributions Grants	$347,844,394	CYContributionsGrantsAmt
PY Program Service Revenue	$29,465	PYProgramServiceRevenueAmt
CY Program Service Revenue	$41,949	CYProgramServiceRevenueAmt
PY Investment Income	$1,742,492	PYInvestmentIncomeAmt
CY Investment Income	$2,168,657	CYInvestmentIncomeAmt
PY Other Revenue	$4,668,393	PYOtherRevenueAmt
CY Other Revenue	$5,225,302	CYOtherRevenueAmt
PY Total Revenue	$304,756,338	PYTotalRevenueAmt
CY Total Revenue	$355,280,302	CYTotalRevenueAmt
PY Grants And Similar Paid	$67,139,518	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$66,754,537	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$122,728,502	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$136,040,867	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$5,359,356	CYTotalFundraisingExpenseAmt
PY Other Expenses	$116,152,150	PYOtherExpensesAmt
CY Other Expenses	$126,837,131	CYOtherExpensesAmt
PY Total Expenses	$306,020,170	PYTotalExpensesAmt
CY Total Expenses	$329,632,535	CYTotalExpensesAmt
PY Revenues Less Expenses	-$1,263,832	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$25,647,767	CYRevenuesLessExpensesAmt
Total Assets BOY	$450,940,286	TotalAssetsBOYAmt
Total Assets EOY	$467,947,698	TotalAssetsEOYAmt
Total Liabilities BOY	$53,692,915	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$50,797,492	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$397,247,371	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$417,150,206	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	PATH'S MISSION IS TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD BY ADVANCING TECHNOLOGIES, STRENGTHENING SYSTEMS, AND ENCOURAGING HEALTHY BEHAVIORS. (CONTINUED ON SCHEDULE O)	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$93,028,818	ExpenseAmt
Grant	$36,175,386	GrantAmt
Desc	ESSENTIAL MEDICINES: PATH IS A GLOBAL LEADER IN IDENTIFYING, DEVELOPING, AND INTRODUCING AFFORDABLE, EFFECTIVE, AND EASY-TO-USE ESSENTIAL MEDICINES, SUCH AS VACCINES AND DRUGS. WE WORK WITH GOVERNMENTS, NONGOVERNMENTAL ORGANIZATIONS, PRIVATE COMPANIES, EDUCATIONAL INSTITUTIONS, AND OTHER GROUPS TO SHEPHERD THESE INNOVATIONS FROM BRIGHT IDEA TO LARGE-SCALE USE.(CONTINUED ON SCHEDULE O)CENTER FOR VACCINE INNOVATION AND ACCESSPATH'S CENTER FOR VACCINE INNOVATION AND ACCESS (CVIA) ALIGNS EXPERTISE ACROSS EVERY STAGE OF VACCINE RESEARCH, DEVELOPMENT, AND INTRODUCTION TO MAKE VACCINES GLOBALLY AVAILABLE TO MORE COMMUNITIES, PARTICULARLY IN LOW- AND MIDDLE-INCOME COUNTRIES. OUR PORTFOLIO INCLUDES MORE THAN TWO DOZEN VACCINE PRODUCTS IN DEVELOPMENT OR ALREADY IN USE, WITH AN EMPHASIS ON THE LEADING INFECTIOUS CAUSES OF CHILD DEATHS AND DISEASE WORLDWIDE.FOR EXAMPLE, IN 2017, WE CONTINUED TO PARTNER WITH COUNTRIES TO EXPAND COVERAGE OF JAPANESE ENCEPHALITIS (JE) VACCINE, WHICH PATH HELPED DEVELOP AND SHEPHERDED THROUGH THE GLOBAL REGULATORY PROCESS. WITH SUPPORT FROM PATH, THE GOVERNMENT OF MYANMAR LAUNCHED A NEW SERIES OF JE IMMUNIZATION CAMPAIGNS, FOLLOWED BY ROUTINE IMMUNIZATION. IN INDONESIA, PATH PROVIDED TECHNICAL ASSISTANCE IN THE LEAD-UP TO JE VACCINATION CAMPAIGNS IN THE PROVINCE OF BALI. WE ALSO CONTINUED TO EVALUATE THE LONG-TERM IMMUNE RESPONSES TO MENAFRIVAC, A LOW-COST VACCINE DEVELOPED BY PATH, THE WORLD HEALTH ORGANIZATION, AND VACCINE MANUFACTURER SERUM INSTITUTE OF INDIA PVT. LTD. THIS VACCINE PROTECTS CHILDREN AND YOUNG ADULTS FROM DEBILITATING AND OFTEN DEADLY SEROGROUP A MENINGOCOCCAL MENINGITIS. IN 2017, WE INITIATED WITH OUR PARTNERS A PHASE 2 STUDY OF A VACCINE TO PROTECT AGAINST OTHER SEROGROUPS OF MENINGOCOCCAL MENINGITIS.TO PREVENT MALARIA, PATH IS ACCELERATING THE DEVELOPMENT OF A WIDE VARIETY OF MALARIA VACCINE CANDIDATES AND APPROACHES. IN 2017, PATH CONTINUED TO WORK WITH THE WORLD HEALTH ORGANIZATION AND OTHER PARTNERS TO PREPARE FOR PILOT IMPLEMENTATION OF THE RTS,S VACCINE IN SELECTED AREAS OF GHANA, KENYA, AND MALAWI. WITH PARTNERS, PATH CONTINUED TO ADVANCE RESEARCH INTO WHETHER, BY REDUCING DOSE LEVEL AND DELAYING THE ADMINISTRATION OF VACCINE DOSES, RTS,S HAS THE POTENTIAL TO AID MALARIA ELIMINATION EFFORTS. FIELD TESTING OF THE DELAYED FRACTIONAL DOSE REGIMEN BEGAN AT A RESEARCH CENTER IN GHANA IN THE FALL OF 2017.PATH'S DEFEAT DIARRHEAL DISEASE INITIATIVE, HOUSED WITHIN CVIA, CONTINUED ITS ONGOING WORK TO GENERATE INVESTMENTS IN ROTAVIRUS, ENTEROTOXIGENIC ESCHERICHIA COLI, AND SHIGELLA VACCINES. IN 2017, WE DEVELOPED AND DISSEMINATED A COMPREHENSIVE REPORT ON DIARRHEAL DISEASE BURDEN AND THE TOOLS AVAILABLE TO REDUCE MORTALITY AND MORBIDITY. WE CONTINUED EDUCATING OUR TARGET AUDIENCES ON THE LIFELONG CONSEQUENCES OF REPEATED INFECTIONS.IN 2017, PATH CONTINUED TO SUPPORT SOUTH AFRICAN VACCINE MANUFACTURER THE BIOVAC INSTITUTE IN PRECLINICAL DEVELOPMENT OF A VACCINE AGAINST GROUP B STREPTOCOCCUS, A LEADING CAUSE OF SEPSIS AND MENINGITIS IN YOUNG INFANTS WORLDWIDE. THE INTENDED VACCINE POPULATION IS PREGNANT WOMEN-PART OF A STRATEGY THAT BOOSTS IMMUNITY AGAINST THE BACTERIUM AND TRANSFERS PROTECTIVE ANTIBODIES TO THE DEVELOPING BABY. ALSO IN 2017, PATH BEGAN A NEW PROJECT TO COORDINATE A CONSORTIUM OF NINE RESEARCH INSTITUTIONS TO COLLATE AND SYNTHESIZE EXISTING EVIDENCE AND EVALUATE NEW DATA ON THE POTENTIAL FOR SINGLE-DOSE DELIVERY OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE. ALTHOUGH MANY COUNTRIES HAVE INTRODUCED HPV VACCINES INTO THEIR NATIONAL IMMUNIZATION SCHEDULES ON A TWO- OR THREE-DOSE SCHEDULE, ROLLOUT IN LOW- AND LOWER-MIDDLE-INCOME COUNTRIES HAS OFTEN LAGGED DUE TO FINANCIAL, LOGISTICAL, OR OTHER BARRIERS. FOR THESE COUNTRIES, A SINGLE-DOSE REGIMEN COULD ACCELERATE INTRODUCTION OF HPV VACCINE INTO NATIONAL IMMUNIZATION SCHEDULES.DRUG DEVELOPMENTPATH AND OUR PARTNERS DEVELOP AND ADVANCE AFFORDABLE DRUGS TO PREVENT AND TREAT DISEASES THAT DISPROPORTIONATELY AFFECT PEOPLE IN LOW-INCOME COUNTRIES, INCLUDING ENTERIC AND DIARRHEAL DISEASES, NEGLECTED TROPICAL DISEASES, HIV/AIDS, AND MALARIA. DRAWING ON AN ENDURING COMMITMENT TO HEALTH EQUITY AND A UNIQUE PARTNERSHIP APPROACH THAT SPANS THE ACADEMIC, PRIVATE, AND NONPROFIT SECTORS, THIS WORK DEMONSTRATES THAT IT IS POSSIBLE TO REACH THE WORLD'S MOST VULNERABLE PEOPLE WITH THE MEDICINES THEY NEED. THIS YEAR, OUR WORK CONTINUED TO OVERTURN BARRIERS TO HEALTH AT EVERY STAGE OF DRUG DEVELOPMENT AND USE-FROM EARLY RESEARCH TO BROAD SCALE-UP.IN 2017, WE CONTINUED OUR WORK TO BREAK THE CYCLE OF INFECTIONS WITH SOIL-TRANSMITTED HELMINTHS. THESE INTESTINAL PARASITIC WORMS THRIVE IN AREAS WITH LIMITED SANITATION AND HYGIENE, WHERE THEY ARE TRANSMITTED THROUGH CONTACT WITH SOIL AND WATER CONTAMINATED BY THE PRACTICE OF OPEN DEFECATION. GLOBALLY, THEY AFFECT MORE THAN A BILLION PEOPLE. THROUGH A MULTIPRONGED APPROACH THAT INCLUDES DRUGS AND DIAGNOSTICS AS WELL AS IMPROVED SANITATION, PATH IS WORKING TO BREAK THE CYCLE OF CHRONIC INFECTIONS AND REDUCE THE BURDEN OF ILLNESS WORLDWIDE, INCLUDING OUR COMMITMENT TO SEEK US FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR THE DRUG TRIBENDIMIDINE AS A SIGNIFICANTLY IMPROVED PERIODIC PRESUMPTIVE TREATMENT FOR HOOKWORM INFECTIONS. FDA APPROVAL IS THE INITIAL STEP IN A PLAN TO INCORPORATE TRIBENDIMIDINE INTO MASS DEWORMING CAMPAIGNS IN LOW-RESOURCE SETTINGS WHERE SOIL-TRANSMITTED HELMINTH INFECTIONS CAUSE SIGNIFICANT MORBIDITY. IN COLLABORATION WITH OTHER GROUPS AND WITH FUNDING FROM THE UNITED KINGDOM'S DEPARTMENT FOR INTERNATIONAL DEVELOPMENT, PATH ALSO CONTINUED TO EXPAND AND STRENGTHEN THE PORTFOLIO OF TOOLS AND TREATMENT OPTIONS FOR DIARRHEAL AND ENTERIC DISEASES. EFFORTS INCLUDE DEVELOPING NEW THERAPEUTICS FOR CRYPTOSPORIDIUM, ONE OF THE KEY PATHOGENS RESPONSIBLE FOR DIARRHEAL MORBIDITY IN CHILDREN UNDER FIVE YEARS OF AGE; ADVANCING INNOVATIVE TREATMENT FOR ENVIRONMENTAL ENTERIC DYSFUNCTION; AND DEVELOPING THE INVESTIGATIONAL NEW DRUG IOWH032 AS AN ANTISECRETORY THERAPY FOR THE TREATMENT OF ACUTE SECRETORY DIARRHEA.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$77,998,825	ExpenseAmt
Grant	$12,141,307	GrantAmt
Revenue	$2,640	RevenueAmt
Desc	PUBLIC HEALTH: PATH'S PUBLIC HEALTH PORTFOLIO FOCUSES ON THREE PRIMARY AREAS. FIRST, WE WORK TO COMBAT INFECTIOUS DISEASES, WITH EMPHASIS ON MALARIA, HIV/AIDS, TUBERCULOSIS (TB), AND NEGLECTED TROPICAL DISEASES. WE ALSO WORK TO SUPPORT THE HEALTH OF KEY POPULATIONS-INCLUDING NEWBORNS, CHILDREN, ADOLESCENTS, AND MOTHERS-AND TO IMPROVE WOMEN'S HEALTH AND SEXUAL AND REPRODUCTIVE HEALTH. FINALLY, WE TARGET EMERGING ISSUES THROUGH OUR WORK ON DIGITAL HEALTH SOLUTIONS, NONCOMMUNICABLE DISEASES, NUTRITION INNOVATIONS, AND HEALTH SYSTEMS STRENGTHENING AND EPIDEMIC PREPAREDNESS.(CONTINUED ON SCHEDULE O)MALARIAPATH PARTNERS WITH GOVERNMENTS, THE PRIVATE SECTOR, AND FUNDERS ACROSS THE GLOBE TO BRING THE WORLD CLOSER TO MALARIA ERADICATION. MORE THAN 200 PATH STAFF MEMBERS WORK ON MALARIA IN MORE THAN 30 COUNTRIES. OUR STRATEGY INCLUDES OPTIMIZING THE DELIVERY OF CURRENT TOOLS AND APPROACHES TO ENSURE THEY REACH THE PEOPLE WHO NEED THEM, DEVELOPING NEW STRATEGIES FOR ELIMINATION, DEVELOPING NEXT-GENERATION TOOLS TO OVERCOME EMERGING CHALLENGES, AND CREATING INNOVATIVE PARTNERSHIPS AND FUNDING MODELS TO ENSURE THAT OUR PROGRAMS ARE SUSTAINABLE AND EFFICACIOUS. PATH-PIONEERED APPROACHES HAVE CONTRIBUTED TO REMARKABLE PROGRESS TOWARD CONTROLLING AND ELIMINATING MALARIA, WITH NEARLY 7 MILLION LIVES SAVED SINCE 2000.IN 2017, OUR MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROGRAM CONTINUED TO SUPPORT THE GOVERNMENTS OF ETHIOPIA, SENEGAL, AND ZAMBIA IN THEIR MALARIA ELIMINATION GOALS BY SCALING UP PREVENTION AND TREATMENT, EVALUATING SENSITIVE DIAGNOSTIC TOOLS, ESTABLISHING RAPID REPORTING SYSTEMS, AND CONTINUING TO SUPPORT POPULATION-WIDE, DRUG-BASED STRATEGIES SUCH AS MASS DRUG ADMINISTRATION. PATH ALSO CONTINUED EFFORTS TO IMPROVE DATA FOR MALARIA CONTROL DECISION-MAKING AND SURVEILLANCE. IN ZAMBIA, THE VISUALIZE NO MALARIA PROJECT-A GROUNDBREAKING PARTNERSHIP WITH A SEATTLE-BASED SOFTWARE COMPANY AND A COALITION OF OTHER TECHNOLOGY COMPANIES-CONTINUED TO EXPAND. THIS PROJECT EQUIPS HEALTH WORKERS AND OFFICIALS WITH THE REAL-TIME DATA VISUALIZATION TOOLS THEY NEED TO SEE AND UNDERSTAND WHERE MALARIA IS APPEARING SO THEY CAN APPROPRIATELY DEPLOY RESOURCES TO HALT ITS SPREAD. FURTHERMORE, TO BOLSTER SURVEILLANCE IN WESTERN KENYA, PATH ASSESSED THE POTENTIAL CONTRIBUTION OF MALARIA TESTING DATA FROM PREGNANT WOMEN ATTENDING ANTENATAL CLINICS.IN 2017, PATH ALSO CONTINUED TO WORK WITH THE WORLD HEALTH ORGANIZATION AND OTHER PARTNERS TO PREPARE FOR PILOT IMPLEMENTATION OF THE RTS,S MALARIA VACCINE IN SELECTED AREAS OF GHANA, KENYA, AND MALAWI. VACCINATIONS ARE DUE TO BEGIN IN 2019. AMONG THE NEW TOOLS DEVELOPED AND EVALUATED BY PATH IN 2017 WERE NEXT-GENERATION INDOOR RESIDUAL SPRAYING (IN PARTNERSHIP WITH THE INNOVATIVE VECTOR CONTROL CONSORTIUM, THE US PRESIDENT'S MALARIA INITIATIVE, ABT ASSOCIATES, AND THE GLOBAL FUND) AND ATTRACTIVE TARGETED SUGAR BAITS. PATH ALSO SUPPORTED THE DEVELOPMENT OF A NEW, HIGHLY SENSITIVE RAPID DIAGNOSTIC TEST THAT OFFERS A GREATER THAN TENFOLD IMPROVEMENT IN DETECTION OF THE MOST COMMON MALARIA PARASITE. IN ADDITION, WE ADVANCED WORK ON A POINT-OF-CARE DIAGNOSTIC TEST FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, A CONDITION THAT CAN COMPLICATE MALARIA TREATMENT. HIV EPIDEMIC CONTROLPATH CONTINUED TO CONTRIBUTE TO HIV EPIDEMIC CONTROL IN 2017 BY FOCUSING PROGRAMMING ON THE KEY AND HIGH-PRIORITY POPULATIONS OF ADOLESCENT GIRLS AND YOUNG WOMEN, PEOPLE COINFECTED WITH HIV AND TB, SEX WORKERS AND THEIR CLIENTS, MEN WHO HAVE SEX WITH MEN, AND PEOPLE WHO INJECT DRUGS. WE ADVANCED PROGRAMMING ACROSS MULTIPLE TECHNOLOGY AND SERVICE DELIVERY PLATFORMS-FROM DEVICES, TOOLS, AND DIAGNOSTICS TO SERVICE DELIVERY INNOVATIONS AND ADVOCACY. TO DEVELOP MORE AFFORDABLE AND IMPROVED HIV DIAGNOSTICS, PATH EXPLORED NEW PRODUCT DESIGNS FOR AN ORAL FLUID HIV SELF-TEST THAT COULD BE AFFORDABLY MANUFACTURED. PATH ALSO ADVANCED ALTERNATIVE, LOW-COST METHODS TO DELIVER MICROBICIDES AND ANTIRETROVIRAL MEDICATIONS FOR HIV PREVENTION (PRE-EXPOSURE PROPHYLAXIS, OR PREP) AND TREATMENT. THIS INCLUDED WORK ON USE OF MICROARRAY PATCHES TO DELIVER BOTH ANTIRETROVIRALS AND CONTRACEPTIVES AND USE OF A THIN-FILM POLYMER SUBCUTANEOUS IMPLANT FOR SUSTAINED RELEASE OF ANTIRETROVIRALS FOR INFECTION PREVENTION.THROUGH THE AIDS, POPULATION, AND HEALTH INTEGRATED ASSISTANCE PROGRAM PLUS (APHIAPLUS) PROJECT IN WESTERN KENYA, PATH HELPED TO INTEGRATE SERVICES FOR HIV/AIDS, TB, SEXUAL AND REPRODUCTIVE HEALTH, NONCOMMUNICABLE DISEASES, AND OTHER ILLNESSES TO HELP MORE PEOPLE ACCESS A GREATER SPECTRUM OF SERVICES. AS OF DECEMBER 2017, THE PROJECT HAD TESTED MORE THAN 6.7 MILLION INDIVIDUALS FOR HIV AND SUPPORTED MORE THAN 110,900 PEOPLE LIVING WITH HIV/AIDS WHO WERE RECEIVING TREATMENT. WITH FUNDING FROM THE US PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF DREAMS INITIATIVE, APHIAPLUS INTENSIFIED EFFORTS TO REACH MORE THAN 67,000 ADOLESCENT GIRLS AND YOUNG WOMEN WITH INTERVENTIONS TO REDUCE THEIR VULNERABILITY TO HIV AND IMPROVE THEIR ACCESS TO SERVICES. THIS WORK INCLUDED PILOTING PREP AMONG 1,465 YOUNG WOMEN, AMONG WHOM 84 PERCENT WERE RETAINED ON PREP AT THE END OF DECEMBER 2017. IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), PATH FOCUSED HIV/AIDS PROGRAMMING IN THE HIGH-PREVALENCE PROVINCES OF HAUT KATANGA AND LUALABA UNDER THE INTEGRATED HIV/AIDS PROGRAM FUNDED BY THE US AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID). PATH PROVIDED TECHNICAL ASSISTANCE TO 153 FACILITIES ACROSS 16 HEALTH ZONES TO INCREASE TARGETED TESTING EFFORTS, ENROLL ALL IDENTIFIED HIV-POSITIVE INDIVIDUALS ON TREATMENT, SCALE UP VIRAL LOAD TESTING, AND ROLL OUT DIFFERENTIATED CARE MODELS TO IMPROVE RETENTION IN TREATMENT THROUGH VIRAL SUPPRESSION. PATH CONTINUED TO PILOT INNOVATIONS TO REACH MOST-AT-RISK POPULATIONS IN VIETNAM. PATH EQUIPPED SOCIAL AND SUPPORT GROUPS OPERATED BY MEMBERS OF KEY POPULATIONS TO GENERATE DEMAND FOR SERVICES AMONG THEIR PEERS THROUGH TARGETED OUTREACH VIA SOCIAL MEDIA, LINKAGES TO HIV TESTING SERVICES THROUGH MOBILE APPLICATIONS, AND SCALE-UP OF HIV SELF-TESTING AND PREP. TUBERCULOSIS PATH BRINGS GLOBAL HEALTH EXPERTISE AND INNOVATIVE APPROACHES TO THE FIGHT AGAINST TB. IN INDIA, WE IMPLEMENTED THE PUBLIC-PRIVATE INTERFACE AGENCY (PPIA) TO IMPROVE PRIVATE-SECTOR HEALTH CARE PROVIDERS' CONTRIBUTIONS TO TB CONTROL IN MUMBAI'S SLUMS. PATH AND OUR INDIAN PARTNERS RECOGNIZED THAT MANY OF THE MOST VULNERABLE PEOPLE IN INDIA SEEK CARE FROM INFORMAL, OFTEN UNTRAINED, PRIVATE HEALTH CARE PROVIDERS (SUCH AS TRADITIONAL HEALERS), WHO OFTEN CANNOT ACCURATELY DIAGNOSE OR TREAT TB. THE PPIA PROJECT FOCUSED ON DEVELOPING AND ENHANCING THE NATIONAL TB REPORTING MECHANISM "E-NIKSHAY" TO BETTER INCORPORATE PRIVATE-SECTOR PATIENTS INTO THE NATIONAL REPORTING SYSTEM. PATH ALSO CONTINUED TO SUPPORT A VOUCHER MECHANISM TO CONNECT PATIENTS FROM LOCAL INFORMAL PROVIDERS TO QUALIFIED PHYSICIANS, DIAGNOSTIC SERVICES, AND TREATMENT SUPPORT. PPIA HAS DRAMATICALLY IMPROVED ACCESS TO TB SERVICES. IN SOUTH AFRICA, PATH AND OUR PARTNERS DEVELOPED AND IMPLEMENTED A BEHAVIOR CHANGE COMMUNICATION INTERVENTION TO TRAIN HEALTH CARE WORKERS ON TB INFECTION PREVENTION AND CONTROL PRACTICES. PATH DEVELOPED AND PILOTED A TRAINING CURRICULUM AND DEVELOPED, PRETESTED, AND PRODUCED JOB AIDS FOR NURSES TO REINFORCE THEIR LEARNING WHILE ON THE JOB. IN VIETNAM, PATH BUILT ON THE BREATH FOR LIFE PROGRAM, IN WHICH WE PILOTED A MODEL TO STRENGTHEN CHILDHOOD TB CASE DETECTION AND EARLY TREATMENT. ACTIVITIES FOCUSED ON CONCLUDING PROJECT EVALUATIONS AND DOCUMENTING ACHIEVEMENTS AND CHALLENGES. IN TANZANIA, PATH TRAINED AND SUPPORTED COMMUNITY VOLUNTEERS, COMMUNITY-BASED ORGANIZATIONS, AND FORMER TB PATIENTS TO DELIVER COMMUNITY-BASED TB INTERVENTIONS. COMMUNITY WORKERS HELD EVENTS TO INCREASE AWARENESS OF TB, SCREENED AND REFERRED PEOPLE FOR TB TESTING, AND CONDUCTED HOUSEHOLD VISITS TO FAMILIES OF TB PATIENTS FOR EDUCATION, SCREENING, AND TESTING REFERRALS. OUR CONTRIBUTIONS TO THE GLOBAL RESPONSE TO MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) INCLUDED ESTABLISHING A "TEST AND REFER" MODEL IN THE PRIVATE SECTOR IN MUMBAI, INDIA, WHERE WE FOCUSED ON CONNECTING THE PRIVATE AND PUBLIC SECTORS. AS PRIVATE-SECTOR PATIENTS RECEIVED CONFIRMATION OF MDR-TB DIAGNOSES, PATH LINKED THEM TO A PUBLIC-SECTOR MDR-TB TREATMENT CENTER AND PROVIDED SOCIAL SUPPORT (FOR EXAMPLE, PEER-GROUP MEETINGS AND CONNECTIONS WITH COMMUNITY GROUPS). IN UKRAINE, PATH WORKED ON TRANSITIONING THE NATIONAL MDR-TB TREATMENT PROGRAM TO AN AMBULATORY CARE MODEL TO ALLOW PATIENTS TO LIVE AT HOME AND TO WORK WHEN THEY CAN RATHER THAN SPEND TWO YEARS IN A TREATMENT FACILITY. PATH ALSO COLLABORATED WITH USAID TO IMPLEMENT A PILOT STUDY FOR USE OF BEDAQUILINE IN EXTREMELY DRUG-RESISTANT TB PATIENTS. PATH WORKED WITH THE NATIONAL GOVERNMENT TO ENSURE THE DRUG WAS ALLOWED IN COUNTRY FOR THE PILOT AND MONITORED PATIENTS' PROGRESS.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$51,401,296	ExpenseAmt
Grant	$11,377,732	GrantAmt
Desc	INTERNATIONAL DEVELOPMENT: IN 2017, PATH'S INTERNATIONAL DEVELOPMENT PORTFOLIO SUPPORTED WORK IN MORE THAN 70 COUNTRIES, RANGING FROM SMALL-SCALE PILOTS TO LARGE, MULTICOUNTRY EFFORTS. EXAMPLES OF OUR 2017 INTERNATIONAL DEVELOPMENT WORK ARE HIGHLIGHTED BELOW, FOCUSING ON THE DRC, VIETNAM, AND ZAMBIA.(CONTINUED ON SCHEDULE O)FOR ALMOST A DECADE, PATH HAS WORKED ON A VARIETY OF HEALTH ISSUES - SUCH AS HIV, TB, NEGLECTED TROPICAL DISEASES, AND MATERNAL AND CHILD HEALTH - IN THE DEMOCRATIC REPUBLIC OF THE CONGO. RECENTLY, OUR WORK IN THE DRC HAS EXPANDED TO INCLUDE GLOBAL HEALTH SECURITY. IN COLLABORATION WITH THE DRC MINISTRY OF HEALTH AND US CENTERS FOR DISEASE CONTROL AND PREVENTION, PATH OUTLINED A PLAN TO BUILD AN EMERGENCY OPERATIONS CENTER (EOC), WHERE DESIGNATED PUBLIC HEALTH EMERGENCY MANAGEMENT PERSONNEL CAN ASSEMBLE TO COORDINATE STRATEGIC MANAGEMENT OF PUBLIC HEALTH EVENTS AND EMERGENCIES. THE AIM OF THE EOC IS TO BOLSTER THE CAPACITY OF NATIONAL SYSTEMS TO RAPIDLY DETECT AND PREVENT EPIDEMICS.PATH ALSO COORDINATED A VISIT BY DRC HEALTH OFFICIALS TO AN ESTABLISHED EOC IN SENEGAL. THIS VISIT HELPED THE OFFICIALS BETTER UNDERSTAND HOW THE DRC EOC SHOULD BE OPERATIONALIZED AND ORGANIZED. ALTHOUGH THE DRC EOC WAS NOT YET OPERATIONAL DURING THE 2017 EBOLA OUTBREAK IN THE LIKATI HEALTH ZONE, TECHNICAL SUPPORT FROM PATH AND OTHER PARTNERS WAS CRITICAL FOR ENSURING A COORDINATED NATIONAL RESPONSE THAT RAPIDLY CONTAINED THE OUTBREAK. THE OUTBREAK WAS CONTAINED BECAUSE OF THE PROMPT ALERTS AND RAPID RESPONSE FROM THE GOVERNMENT, PATH, AND OTHER PARTNERS. IN 2017, PATH ALSO COMPLETED ACTIVITIES FOR TWO LARGE PROJECTS FUNDED BY USAID: PROVICPLUS AND MALARIACARE. PROVICPLUS WORKED IN FIVE PROVINCES, OFFERING COMPREHENSIVE HIV/AIDS CLINICAL SERVICES IN MORE THAN 100 HEALTH FACILITIES AS WELL AS INNOVATIVE, HIGH-IMPACT MATERNAL AND NEONATAL SERVICES IN 15 PILOT HEALTH FACILITIES. MALARIACARE WORKED ACROSS 14 PROVINCES AND IN KINSHASA TO SCALE UP HIGH-QUALITY DIAGNOSTIC AND TREATMENT SERVICES FOR MALARIA AND OTHER FEBRILE ILLNESSES.FINALLY, PATH LED TWO IMMUNIZATION ADVOCACY PROJECTS IN THE DRC WITH SUPPORT FROM THE BILL & MELINDA GATES FOUNDATION AND GAVI, THE VACCINE ALLIANCE. THESE PROJECTS PROMOTED EXPANDED COVERAGE, EQUITABLE ACCESS, AND SUSTAINABLE FINANCING FOR LIFESAVING IMMUNIZATION PROGRAMS. WE ALSO ADVOCATED IN THE DRC FOR BETTER CARE RELATED TO HUMAN AFRICAN TRYPANOSOMIASIS (SLEEPING SICKNESS), A NEGLECTED TROPICAL DISEASE.IN VIETNAM, PATH CONTINUED TO STRENGTHEN PARTNERSHIPS WITH THE GOVERNMENT, THE PRIVATE SECTOR, AND COMMUNITY-BASED ORGANIZATIONS. IN 2017, PATH EXPANDED THE COMMUNITIES FOR HEALTHY HEARTS PROJECT, WHICH AIMS TO INCREASE AWARENESS OF, ACCESS TO, AND QUALITY OF HYPERTENSION SERVICES FOR LOW-INCOME HOUSEHOLDS IN HO CHI MINH CITY. IN COLLABORATION WITH THE VIETNAM GENERAL DEPARTMENT OF PREVENTIVE MEDICINE AND LOCAL PARTNERS, THE PROJECT INTRODUCED AN INNOVATIVE COMMUNITY-BASED MODEL FOR THE SCREENING, TREATMENT, AND CONTROL OF HIGH BLOOD PRESSURE. AS PART OF THIS PROJECT, PATH DEVELOPED AND USED AN INTERACTIVE BLOOD PRESSURE MANAGEMENT SOFTWARE APPLICATION (EHTN TRACKER). THROUGH PATH'S GLOBAL HEALTH SECURITY PARTNERSHIP WITH THE US CENTERS FOR DISEASE CONTROL AND PREVENTION, WE PROVIDED TECHNICAL ASSISTANCE TO THE MINISTRY OF HEALTH IN VIETNAM TO IMPROVE INFECTIOUS DISEASE SURVEILLANCE SYSTEMS THROUGH BETTER DATA USE AND MANAGEMENT, REAL-TIME SURVEILLANCE, REPORTING, AND DEVELOPMENT OF EMERGENCY OPERATIONS CENTERS (EOCS). THE FIRST EOC OPENED IN HANOI IN 2016, AND PATH SUPPORTED THE OPENING OF ADDITIONAL EOCS IN 2017. THE HEALTHY MARKETS PROJECT, FUNDED BY USAID, AIMS TO GROW VIABLE COMMERCIAL MARKETS FOR HIV-RELATED GOODS AND SERVICES THAT CAN MEET THE NEEDS OF POPULATIONS FACING THE GREATEST HIV RISKS. IN 2017, THE PROJECT HELPED TO INCREASE PRIVATE-SECTOR AND LOCAL INVESTMENT IN THE MARKET FOR CONDOMS AND OTHER HIV-RELATED GOODS AND SERVICES, DEMAND FOR THOSE GOODS AND SERVICES AMONG KEY POPULATIONS, AND THE PRIVATE-SECTOR SUPPLY OF GOODS AND SERVICES. IN ZAMBIA, PATH HAS BEEN ACTIVELY INVOLVED IN STRENGTHENING HEALTH SYSTEMS SINCE 2005, WHEN WE JOINED THE GOVERNMENT OF ZAMBIA'S MINISTRY OF HEALTH AND THE ROLL BACK MALARIA PARTNERSHIP TO LAUNCH A NATIONAL PLAN FOR TACKLING MALARIA AND IMPLEMENTING A COMPREHENSIVE PREVENTION PROGRAM. IN COLLABORATION WITH THE NATIONAL MALARIA CONTROL CENTER, CLINICS, AND COMMUNITY HEALTH WORKERS, PATH CONTINUES TO LEAD A NUMBER OF MALARIA PROJECTS IN ZAMBIA. THROUGH THE MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA), PATH IS SUPPORTING THE MINISTRY OF HEALTH TO DEVELOP A COMPREHENSIVE SET OF STRATEGIES TO REDUCE CASES AND DEATHS FROM MALARIA IN TARGET AREAS BY SCALING UP USE OF EXISTING TOOLS, SUCH AS BEDNETS AND INDOOR SPRAYING OF INSECTICIDES. PATH HELPED THE ZAMBIAN GOVERNMENT SET UP A RAPID REPORTING SYSTEM IN ONE-THIRD OF THE COUNTRY'S HEALTH FACILITIES TO PROVIDE NEAR REAL-TIME DATA ON MALARIA CASES AND AVAILABLE SUPPLIES. WITH DATA ENTRY AND DATA SUBMISSION BY CELL PHONE, HEALTH OFFICIALS NO LONGER NEED TO WAIT MONTHS FOR THE INFORMATION THEY NEED TO MAKE DECISIONS AND ALLOCATE RESOURCES IN THE FIGHT AGAINST MALARIA. TO ACHIEVE THE GOAL OF ZERO MALARIA TRANSMISSION, PATH CONTINUES TO ADVANCE MORE SENSITIVE DIAGNOSTIC TOOLS, TEST NEW TREATMENT APPROACHES, AND COMBINE NEW DIAGNOSTIC AND TREATMENT METHODS TO PERMANENTLY STOP MALARIA TRANSMISSION. THIS HAS LED TO THE CREATION OF "MALARIA-FREE ZONES," BRINGING ZAMBIA CLOSER TO MALARIA ELIMINATION.IN ADDITION, PATH PARTNERED WITH THE GOVERNMENT OF ZAMBIA IN THE USAID-FUNDED PROGRAM FOR THE ADVANCEMENT OF MALARIA OUTCOMES PROJECT. THIS PROJECT STRENGTHENS MALARIA PREVENTION AND CASE MANAGEMENT ACTIVITIES AT HEALTH FACILITIES AND AT THE COMMUNITY LEVEL; BUILDS MANAGEMENT CAPACITY AT THE DISTRICT AND PROVINCIAL LEVEL TO PROVIDE OVERSIGHT OF MALARIA INTERVENTIONS; IMPROVES DATA REPORTING, ANALYSIS, AND USE FOR DECISION-MAKING; AND EMPOWERS COMMUNITIES TO TAKE OWNERSHIP OF THE MALARIA PROBLEM. PATH ALSO LED THE ERADICATE TB PROJECT IN ZAMBIA. WITH A FOCUS ON SIX OF ZAMBIA'S TEN PROVINCES, THE PROJECT PARTNERED WITH THE NATIONAL TUBERCULOSIS CONTROL PROGRAM AND OTHER ORGANIZATIONS TO IMPROVE DIAGNOSIS AND TREATMENT SUCCESS RATES.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$34,074,525	ExpenseAmt
Grant	$7,060,111	GrantAmt
Revenue	$39,309	RevenueAmt
Desc	ADVOCACY AND PUBLIC POLICY:PATH'S ADVOCACY AND PUBLIC POLICY TEAM WORKS IN THE UNITED STATES, WITH MULTILATERAL AGENCIES ENGAGED IN GLOBAL HEALTH POLICY AND PLANNING, AND IN COUNTRIES AND COMMUNITIES AROUND THE WORLD. WE HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH EFFORTS. IN 2017, PATH LED ADVOCACY EFFORTS TO ENSURE SUPPORT AMONG POLICYMAKERS IN THE UNITED STATES AND EUROPE FOR RESEARCH AND DEVELOPMENT, MATERNAL AND CHILD HEALTH, IMMUNIZATION, AND GLOBAL HEALTH SECURITY. ONE EXAMPLE OF OUR SUCCESS WAS PUBLICATION OF AN ANALYSIS OF US GOVERNMENT POLICIES FOR INTERNATIONAL ACTION TO STRENGTHEN CAPACITY IN LOW- AND MIDDLE-INCOME COUNTRIES TO PREVENT THE NEXT PANDEMIC. THE REPORT GARNERED WIDESPREAD INTEREST AMONG US POLICYMAKERS AND INFLUENCERS AND LAID THE GROUNDWORK FOR ONGOING ADVOCACY TO PROTECT VITAL HEALTH SECURITY PROGRAMS. WORKING WITH PARTNERS IN AFRICAN COUNTRIES, WE HELPED ADVANCE POLICIES TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN. AMONG MANY ACHIEVEMENTS THIS YEAR, THE GOVERNMENT IN KAKAMEGA COUNTY, KENYA, SECURED PASSAGE OF THE KAKAMEGA COUNTY MATERNAL AND CHILD HEALTH AND FAMILY PLANNING ACT OF 2017, CREATING THE LEGAL FRAMEWORK TO ENSURE SUSTAINABLE FUNDING FOR THE COUNTY'S FLAGSHIP MATERNAL, NEWBORN, AND CHILD HEALTH AND FAMILY PLANNING PROGRAM. IN THE DRC, THE GOVERNMENT OF TSHOPO PROVINCE VOTED TO PASS AN EDICT TO ENABLE THE MOBILIZATION OF LOCAL RESOURCES FOR IMMUNIZATION. IN SOUTH AFRICA, PATH'S ADVOCACY INFLUENCED THE CREATION AND STRUCTURE OF A NEW ENTITY TO MORE EFFECTIVELY REGULATE HEALTH PRODUCTS.MARKET DYNAMICS:PATH'S MARKET DYNAMICS PROGRAM ENCOMPASSES EFFORTS TO CHARACTERIZE MARKETS, ASSESS SHORTCOMINGS, AND DESIGN MARKET-BASED INTERVENTIONS TO IMPROVE HEALTH OUTCOMES. THIS WORK COMPLEMENTS PATH'S OTHER EFFORTS, SUCH AS PRODUCT DEVELOPMENT AND INTRODUCTION. IT BUILDS UPON OUR EXISTING STRENGTH IN COMMERCIALIZATION, ALIGNS EXPERTISE ACROSS TEAMS, AND EXPANDS OUR CAPACITY TO ADDRESS MARKET-BASED ISSUES. IN 2017, OUR WORK FOCUSED ON ASSESSING MARKETS AND IMPROVING MARKET FUNCTIONING FOR MALARIA DRUGS AND DRUG INTERMEDIATES, MALARIA DIAGNOSTICS, OXYGEN THERAPY DEVICES, DEVICES FOR TREATMENT OF PRECANCEROUS CERVICAL LESIONS, AND DEVICES FOR WATER TREATMENT. THE MARKET DYNAMICS PROGRAM ALSO COLLABORATED WITH THE ADVOCACY AND PUBLIC POLICY TEAM TO STRENGTHEN MARKETS FOR MATERNAL AND NEWBORN HEALTH PRODUCTS THROUGH POLICY ADVOCACY. TECHNOLOGY DEVELOPMENT AND INTRODUCTION:PATH'S TECHNOLOGY DEVELOPMENT AND INTRODUCTION (TDI) DIVISION IS AN INTEGRATED GLOBAL PLATFORM FOR END-TO-END ADVANCEMENT OF HIGH-IMPACT DEVICES, TOOLS, AND DIAGNOSTICS THAT ADDRESS GLOBAL, REGIONAL, AND COUNTRY HEALTH NEEDS. IT IS ORGANIZED AS A NETWORK OF "IMPACT LABS" WITH FUNCTIONAL EXPERTISE AND RELATIONSHIPS WITH DONORS, ENTREPRENEURS, HEALTH CARE PROVIDERS, ACADEMIA, RESEARCH INSTITUTES, AND POLICYMAKERS IN INDIA, SOUTH AFRICA, AND THE UNITED STATES.THE DEVICES AND TOOLS PROGRAM WITHIN THE TDI DIVISION IS PATH'S INNOVATIVE TECHNOLOGY ARM. THE GROUP WORKS WITH PARTNERS AROUND THE WORLD TO DEVELOP, TEST, REFINE, INTRODUCE, AND SCALE AFFORDABLE TECHNOLOGIES TO IMPROVE THE HEALTH AND LIVES OF THOSE LIVING IN LOW- AND MIDDLE-INCOME COUNTRIES.IN 2017, THE DEVICES AND TOOLS PROGRAM CELEBRATED A NUMBER OF MILESTONES. FOR EXAMPLE, THE FIRST FREEZE-PREVENTION VACCINE CARRIER BASED ON PATH'S REFERENCE DESIGN WAS PREQUALIFIED BY THE WORLD HEALTH ORGANIZATION. PATH ALSO PUBLISHED FROM RESEARCH TO USE: SAVING NEWBORN LIVES WITH CHLORHEXIDINE FOR UMBILICAL CORD CARE, A COMPREHENSIVE SUMMARY OF OUR TEN-YEAR ROLE AS MARKET MANAGER OF CHLORHEXIDINE FOR UMBILICAL CORD CARE GLOBALLY. IN ADDITION, WE LAUNCHED AND COMPLETED A GLOBAL DESIGN CHALLENGE FOR A LOW-COST, REUSABLE, AND ELECTRICITY-FREE ADJUSTABLE SYRINGE INFUSION PUMP, AND WE REDESIGNED THE SAFISTATION CHLORINE GENERATOR FOR HEALTH CARE FACILITY APPLICATION. FURTHERMORE, STAFF PRODUCED 24 JOURNAL ARTICLES AND REPORTS ON OUR RESEARCH FINDINGS, RANGING FROM DEVELOPING A FLEXIBLE PEDIATRIC DOSAGE FORM FOR ANTIRETROVIRALS: A FAST-DISSOLVING TABLET TO COST-EFFECTIVENESS OF CONDOM BALLOON TAMPONADE TO CONTROL SEVERE POSTPARTUM HEMORRHAGE IN KENYA. PATH'S WORK TO DEVELOP AND INTRODUCE FAST, ACCURATE DIAGNOSTIC TECHNOLOGIES INCLUDES TOOLS TO DETECT AND MONITOR NEGLECTED TROPICAL DISEASES, MALARIA, POLIO, AND NONCOMMUNICABLE DISEASES.IN 2017, OUR PIONEERING WORK IN DIAGNOSTICS FOR MALARIA ELIMINATION INCLUDED DEVELOPING NEW OPTIONS TO IMPROVE DETECTION OF THE MALARIA PARASITE AND TESTS TO GUIDE CLINICAL CARE OF PATIENTS. WITH OUR DEVELOPMENT PARTNERS, PATH ADVANCED SEVERAL NEW PROTOTYPES FOR RAPID TESTS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, A CONDITION THAT CAN COMPLICATE TREATMENT OF PLASMODIUM VIVAX MALARIA. WE ALSO WORKED WITH A PUBLIC-SECTOR PARTNER TO LAUNCH A NEW, HIGHLY SENSITIVE TEST THAT CAN DETECT LOW LEVELS OF PLASMODIUM FALCIPARUM MALARIA INFECTION THAT MIGHT OTHERWISE BE MISSED IN LOW-DENSITY INFECTIONS. IN ADDITION, WE SUPPORTED THE LAUNCH OF A NEW ENZYME-LINKED IMMUNOABSORBENT ASSAY FOR P. FALCIPARUM, DESIGNED FOR USE IN LAB SETTINGS AS A REFERENCE TEST FOR PANELS AND RAPID DIAGNOSTICS.WITH A PRIVATE-SECTOR PARTNER, PATH BROUGHT TO MARKET A NEW MULTIPLEXED TOOL FOR POPULATION-BASED SURVEILLANCE OF MICRONUTRIENT DEFICIENCIES. THIS TEST, WHICH DETECTS UP TO SEVEN NUTRITION- AND DISEASE-RELATED BIOMARKERS IN A SINGLE SAMPLE OF HUMAN SERUM, ADDRESSES THE NEED FOR TOOLS THAT CAN ACCURATELY AND RAPIDLY ASSESS NUTRITIONAL DEFICIENCIES AT A LARGE SCALE.FURTHER, AS PART OF THE GLOBAL EFFORT TO ERADICATE POLIO, PATH AND OUR PARTNERS CONDUCTED STUDIES IN KENYA AND PAKISTAN TO VALIDATE A NEW TOOL TO DETECT POLIOVIRUS IN WASTEWATER AND SEWAGE.PATH'S IMPACT LABS IN INDIA, SOUTH AFRICA, AND THE UNITED STATES HELP TO ADVANCE THE MOST PROMISING HEALTH TECHNOLOGIES. THESE COUNTRIES HAVE RICH INNOVATION ECOSYSTEMS WITH UNIVERSITIES, PRIVATE-SECTOR FIRMS, AND A GROWING NUMBER OF ENTREPRENEURS FOCUSED ON INNOVATIVE PRODUCTS AND SERVICES THAT MAKE HEALTH CARE MORE AFFORDABLE, ACCESSIBLE, AND EFFECTIVE. THROUGH THE NETWORK OF IMPACT LABS, PATH CAN LEVERAGE WORLD-CLASS GLOBAL AND COUNTRY EXPERTISE TO ACCELERATE THE DEVELOPMENT AND INTRODUCTION OF SCALABLE DEVICES, TOOLS, AND DIAGNOSTICS FOR HEALTH.IN 2017, THE INDIA IMPACT LAB CONDUCTED A DETAILED LANDSCAPING TO IDENTIFY GAPS IN HEALTH CARE INNOVATIONS IN INDIA AND BUILT A STRATEGY TO SCALE INNOVATIONS WITH THE HIGHEST POTENTIAL FOR IMPACT. THE INDIA IMPACT LAB HELD DISCUSSIONS WITH STAKEHOLDERS SUCH AS USAID AND THE BILL & MELINDA GATES FOUNDATION AS WELL AS INDIAN STAKEHOLDERS SUCH AS THE DEPARTMENT OF BIOTECHNOLOGY, GOVERNMENT OF INDIA; BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL; INDIAN INSTITUTE OF TECHNOLOGY IN DELHI AND MUMBAI; VILLGRO; AND MANY OTHERS. A DRAFT BUSINESS PLAN WAS CREATED THAT INCLUDED DEVELOPING A PHYSICAL LAB TO SUPPORT INNOVATIVE RESEARCH AND DEVELOPMENT ON THE CAMPUS OF THE INDIAN INSTITUTE OF TECHNOLOGY, DELHI. THE INDIA IMPACT LAB IS BEING DEVELOPED IN PARTNERSHIP WITH TATA TRUSTS AND THE INDIAN INSTITUTE OF TECHNOLOGY, DELHI.SPECIAL INITIATIVES:PATH IS ENGAGED IN A VARIETY OF PROJECTS THAT GALVANIZE OUR EXPERTISE AND RESOURCES AND THOSE OF OUR GLOBAL PARTNERS TO SAVE MORE LIVES, MORE QUICKLY. BY THE END OF 2017, WE HAD ACTIVE HEALTH IMPACT TEAMS IN SEVEN HEALTH AREAS: MALARIA; HIV/AIDS; MATERNAL, NEWBORN, AND CHILD HEALTH; NUTRITION; SEXUAL AND REPRODUCTIVE HEALTH; EPIDEMIC PREPAREDNESS AND RESPONSE/GLOBAL HEALTH SECURITY INNOVATION; AND HEALTH SYSTEMS STRENGTHENING. EACH TEAM GOES THROUGH A STAGED PROCESS OF SCALE-UP AND GROWTH. THESE TEAMS DEVELOP AND EVOLVE STRATEGY, PURSUE NEW OPPORTUNITIES, STRENGTHEN AND CONNECT PATH TALENT ACROSS GEOGRAPHIES AND PROGRAMS, AND POSITION PATH EXTERNALLY TO ENGAGE WITH KEY PARTNERS AND DONORS.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$34,074,525	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$7,060,111	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$39,309	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$256,503,464	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Temp Or Permanent Endowments	Yes (1)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	0	ReportOtherLiabilitiesInd
Include FIN48 Footnote	0	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	Yes (1)	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (1)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (1)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
Info In Schedule O Part V	Yes (X)	InfoInScheduleOPartVInd
IRP Document	274	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	888	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	BE	ForeignCountryCd
Foreign Country	CH	ForeignCountryCd
Foreign Country	CG	ForeignCountryCd
Foreign Country	ET	ForeignCountryCd
Foreign Country	GH	ForeignCountryCd
Foreign Country	IN	ForeignCountryCd
Foreign Country	KE	ForeignCountryCd
Foreign Country	MI	ForeignCountryCd
Foreign Country	MZ	ForeignCountryCd
Foreign Country	OC	ForeignCountryCd
Foreign Country	PE	ForeignCountryCd
Foreign Country	SG	ForeignCountryCd
Foreign Country	SF	ForeignCountryCd
Foreign Country	SZ	ForeignCountryCd
Foreign Country	TZ	ForeignCountryCd
Foreign Country	UG	ForeignCountryCd
Foreign Country	UK	ForeignCountryCd
Foreign Country	UP	ForeignCountryCd
Foreign Country	VM	ForeignCountryCd
Foreign Country	ZA	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	0	QuidProQuoContributionsInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	13	GoverningBodyVotingMembersCnt
Independent Voting Member	13	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	OLIVIA POLIUS CHIEF FINANCIAL OFFICER	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	2062853500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2201 WESTLAKE AVE SUITE 200	AddressLine1Txt
City	SEATTLE	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98121	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
DEAN ALLEN
CHAIR	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
FELIX OLALE
SECRETARY	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
DAVID KING
TREASURER	2.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
JO ADDY
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
PHYLLIS CAMPBELL
DIRECTOR (UNTIL 12/2017)	2.00	0.00	Yes (X)		$0	$0	$0
RAJENDRA VATTIKUTI
DIRECTOR (UNTIL 12/2017)	2.00	0.00	Yes (X)		$0	$0	$0
KEVIN REILLY
DIRECTOR (UNTIL 12/2017)	2.00	0.00	Yes (X)		$0	$0	$0
TSITSI MASIYIWA
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
IREENA VITTAL
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
YEHONG ZHANG
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
LAURIE MICHAELS
DIRECTOR (UNTIL 02/2017)	2.00	0.00	Yes (X)		$0	$0	$0
PEGGY JOHNSON
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
GARY LOCKE
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
BRUCE MCNAMER
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
DEANNA OPPENHEIMER
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
DENNIS SCHMATZ
DIRECTOR	2.00	0.00	Yes (X)		$0	$0	$0
JOHN-ARNE ROTTINGEN
DIRECTOR (BEGAN 09/2017)	2.00	0.00	Yes (X)		$0	$0	$0
STEPHEN B DAVIS
PRESIDENT AND CEO	38.00	2.00		Yes (X)	$641,522	$0	$65,784
OLIVIA D POLIUS
CHIEF FINANCIAL OFFICER	38.00	2.00		Yes (X)	$311,327	$0	$53,104
DANIEL LASTER
COO AND GENERAL COUNSEL	38.00	2.00		Yes (X)	$334,058	$0	$41,018
DAVID C KASLOW
VP - PRODUCT DEVELOPMENT	38.00	2.00			$368,007	$0	$67,708	Yes (X)
AMIE E BATSON
CHIEF STRATEGY OFFICER	39.00	1.00			$312,831	$0	$27,395	Yes (X)
KATHY CAHILL
VP - INTERNATIONAL DEVELOPMENT	40.00	0.00			$284,829	$0	$37,911	Yes (X)
DAVID W FLEMING
VP - PUBLIC HEALTH	40.00	0.00			$274,501	$0	$48,640	Yes (X)
KATHRYN A O'DRISCOLL
CHIEF HUMAN RESOURCES OFFICER	40.00	0.00			$243,636	$0	$44,732	Yes (X)
MARK D MURRAY
VP - GLOBAL ENGAGEMENT	40.00	0.00			$265,839	$0	$52,278	Yes (X)
JEFFREY D BERSON
DIRECTOR	40.00	0.00			$455,662	$0	$49,189		Yes (X)
JAMES B MCKENNA
ASSOCIATE DIRECTOR	40.00	0.00			$432,104	$0	$70,162		Yes (X)
RIKKA E TRANGSRUD
COUNTRY PROGRAM LEADER	40.00	0.00			$376,823	$0	$42,644		Yes (X)
TRAD M HATTON
CHIEF OF PARTY	40.00	0.00			$312,846	$0	$42,663		Yes (X)
BRUCE LAMONT INNIS
GLOBAL DISEASE AREA HEAD	40.00	0.00			$310,470	$0	$20,804		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$4,924,455	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$664,032	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	310	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
UNIT4 BUSINESS SOFTWARE INC
3 BURLINGTON WOODS STE 201	BURLINGTON	MA	01803	SYSTEMS CONTRACTOR	$1,189,741
WIDENET CONSULTING GROUP LLC
11400 SE 6TH ST 130	BELLEVUE	WA	98004	CONSULTING	$1,187,337
MATISIA INC
8259 122ND AVE NW	KIRKLAND	WA	98033	CONSULTING	$1,105,867
TARGET CW
9475 CHESAPEAKE DRIVE	SAN DIEGO	CA	92123	GENERAL CONTRACTOR	$745,823
ZIMNEY & COMPANY LLC
1805 17TH AVE S	SEATTLE	WA	98144	CONSULTING	$594,481

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	35	CntrctRcvdGreaterThan100KCnt
Related Organizations	$19,397,597	RelatedOrganizationsAmt
Government Grants	$147,271,858	GovernmentGrantsAmt
All Other Contributions	$181,174,939	AllOtherContributionsAmt
Noncash Contributions	$151,397	NoncashContributionsAmt
Total Contributions	$347,844,394	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
HONORARIUM	900099	$41,309	$41,309
CONSULTANCIES	541900	$640	$640

Field	Value	IRS element (for citing)
Total Program Service Revenue	$41,949	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,050,888	TotalRevenueColumnAmt
Exclusion	$2,050,888	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$106,646,841	SecuritiesAmt
Other	$99,000	OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$106,458,641	SecuritiesAmt
Other	$169,431	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$188,200	SecuritiesAmt
Other	-$70,431	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$117,769	TotalRevenueColumnAmt
Exclusion	$117,769	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt
GAIN-FOREIGN EXCH.	900099	$4,809,370	$4,809,370
OTHER	900099	$292,651	$292,651
REIMBURSEMENTS	900099	$123,281	$123,281

Field	Value	IRS element (for citing)
Other Revenue Total	$5,225,302	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$355,280,302	TotalRevenueColumnAmt
Related Or Exempt Func Income	$41,949	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$7,393,959	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$27,313,411	TotalAmt
Program Services	$27,313,411	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$39,441,126	TotalAmt
Program Services	$39,441,126	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$3,475,120	TotalAmt
Program Services	$994,452	ProgramServicesAmt
Management And General	$2,392,133	ManagementAndGeneralAmt
Fundraising	$88,535	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$101,634,794	TotalAmt
Program Services	$60,251,989	ProgramServicesAmt
Management And General	$39,740,741	ManagementAndGeneralAmt
Fundraising	$1,642,064	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$9,740,276	TotalAmt
Management And General	$9,740,276	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$14,183,844	TotalAmt
Program Services	$640,928	ProgramServicesAmt
Management And General	$13,542,916	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$7,006,833	TotalAmt
Program Services	$354,682	ProgramServicesAmt
Management And General	$6,652,151	ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$416,815	TotalAmt
Program Services	$128,103	ProgramServicesAmt
Management And General	$288,712	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$405,034	TotalAmt
Program Services	$41,218	ProgramServicesAmt
Management And General	$363,816	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$52,700	TotalAmt
Program Services	$24,037	ProgramServicesAmt
Management And General	$28,663	ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$114,707	TotalAmt
Management And General	$99,068	ManagementAndGeneralAmt
Fundraising	$15,639	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$19,959,185	TotalAmt
Program Services	$12,687,248	ProgramServicesAmt
Management And General	$7,139,961	ManagementAndGeneralAmt
Fundraising	$131,976	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$643,361	TotalAmt
Program Services	$338,099	ProgramServicesAmt
Management And General	$156,226	ManagementAndGeneralAmt
Fundraising	$149,036	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$5,800,231	TotalAmt
Program Services	$4,417,921	ProgramServicesAmt
Management And General	$1,285,223	ManagementAndGeneralAmt
Fundraising	$97,087	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,343,691	TotalAmt
Program Services	$316,255	ProgramServicesAmt
Management And General	$967,056	ManagementAndGeneralAmt
Fundraising	$60,380	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$102,199	TotalAmt
Program Services	$83,970	ProgramServicesAmt
Management And General	$18,229	ManagementAndGeneralAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$11,601,351	TotalAmt
Program Services	$54,763	ProgramServicesAmt
Management And General	$11,546,588	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$21,950,704	TotalAmt
Program Services	$18,900,358	ProgramServicesAmt
Management And General	$2,974,655	ManagementAndGeneralAmt
Fundraising	$75,691	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$9,788,405	TotalAmt
Program Services	$8,565,998	ProgramServicesAmt
Management And General	$790,928	ManagementAndGeneralAmt
Fundraising	$431,479	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$19,155	TotalAmt
Management And General	$19,155	ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$2,757,486	TotalAmt
Program Services	$741,754	ProgramServicesAmt
Management And General	$2,015,732	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$598,672	TotalAmt
Program Services	$161,821	ProgramServicesAmt
Management And General	$436,851	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
SUBCONTRACTS	$27,565,528	$23,554,369	$2,792,494	$1,218,665
EQUIP RENT & MAINT	$5,613,160	$3,830,488	$1,694,477	$88,195
LEAVE & BENS ALLOC	$0	$31,946,262	-$32,863,688	$917,426
FACILITIES ALLOC	$0	$11,599,317	-$11,996,684	$397,367

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$18,104,747	TotalAmt
Program Services	$10,114,895	ProgramServicesAmt
Management And General	$7,944,036	ManagementAndGeneralAmt
Fundraising	$45,816	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$329,632,535	TotalAmt
Program Services	$256,503,464	ProgramServicesAmt
Management And General	$67,769,715	ManagementAndGeneralAmt
Fundraising	$5,359,356	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$101,995,891	BOYAmt
EOY	$3,035,980	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$1,334,550	BOYAmt
EOY	$3,493,254	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$213,222,701	BOYAmt
EOY	$254,454,281	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$7,385,621	BOYAmt
EOY	$13,578,928	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$6,129,231	BOYAmt
EOY	$4,753,758	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$35,725,702	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$23,847,497	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$13,227,227	BOYAmt
EOY	$11,878,205	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$107,031,338	BOYAmt
EOY	$176,133,425	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$439,232	BOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$174,495	BOYAmt
EOY	$619,867	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$450,940,286	BOYAmt
EOY	$467,947,698	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$52,167,762	BOYAmt
EOY	$50,220,817	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$1,525,153	BOYAmt
EOY	$576,675	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$53,692,915	BOYAmt
EOY	$50,797,492	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$25,545,902	BOYAmt
EOY	$25,292,293	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$368,307,703	BOYAmt
EOY	$388,460,737	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$3,393,766	BOYAmt
EOY	$3,397,176	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$397,247,371	BOYAmt
EOY	$417,150,206	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$450,940,286	BOYAmt
EOY	$467,947,698	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$25,647,767	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$1,311,507	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	-$7,056,439	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	Yes (1)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (1)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$260,656,932	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$286,891,535	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$243,499,792	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$298,315,988	CurrentTaxYearMinus1YearAmt
Current Tax Year	$347,844,394	CurrentTaxYearAmt
Total	$1,437,208,641	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$260,656,932	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$286,891,535	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$243,499,792	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$298,315,988	CurrentTaxYearMinus1YearAmt
Current Tax Year	$347,844,394	CurrentTaxYearAmt
Total	$1,437,208,641	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$573,342,575	SubstantialContributorsTotAmt
Public Support Total170	$863,866,066	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$1,577,831	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$1,370,599	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$1,471,233	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,797,794	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,050,888	CurrentTaxYearAmt
Total	$8,268,345	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus3 Years	$38,502	CurrentTaxYearMinus3YearsAmt
Total	$38,502	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,432,891	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$763,131	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$2,551,502	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$4,668,393	CurrentTaxYearMinus1YearAmt
Current Tax Year	$5,225,302	CurrentTaxYearAmt
Total	$15,641,219	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$1,461,156,707	TotalSupportAmt
Gross Receipts Rltd Activities	$253,143	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.59120	PublicSupportCY170Pct
Public Support PY170	0.62930	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$127,336	FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$166,760	FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$294,096	FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$329,338,439	FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$329,632,535	FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$222,686	CurrentYearMinus3Amt
Current Year Minus2	$156,961	CurrentYearMinus2Amt
Current Year Minus1	$168,991	CurrentYearMinus1Amt
Current Year	$294,096	CurrentYearAmt
Total	$842,734	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,207	CurrentYearMinus3Amt
Current Year Minus2	$14,461	CurrentYearMinus2Amt
Current Year Minus1	$470	CurrentYearMinus1Amt
Current Year	$127,336	CurrentYearAmt
Total	$143,474	TotalAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,339,249	BeginningYearBalanceAmt
Contributions	$3,410	ContributionsAmt
Investment Earnings Or Losses	$1,159,282	InvestmentEarningsOrLossesAmt
Other Expenditures	$445,396	OtherExpendituresAmt
End Year Balance	$10,056,545	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$8,897,224	BeginningYearBalanceAmt
Contributions	$4,256	ContributionsAmt
Investment Earnings Or Losses	$907,978	InvestmentEarningsOrLossesAmt
Other Expenditures	$470,209	OtherExpendituresAmt
End Year Balance	$9,339,249	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,404,188	BeginningYearBalanceAmt
Contributions	$2,665	ContributionsAmt
Investment Earnings Or Losses	-$58,783	InvestmentEarningsOrLossesAmt
Other Expenditures	$450,846	OtherExpendituresAmt
End Year Balance	$8,897,224	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,016,994	BeginningYearBalanceAmt
Contributions	$9,350	ContributionsAmt
Investment Earnings Or Losses	$768,184	InvestmentEarningsOrLossesAmt
Other Expenditures	$390,340	OtherExpendituresAmt
End Year Balance	$9,404,188	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,806,786	BeginningYearBalanceAmt
Contributions	$2,550	ContributionsAmt
Investment Earnings Or Losses	$1,503,301	InvestmentEarningsOrLossesAmt
Other Expenditures	$295,643	OtherExpendituresAmt
End Year Balance	$9,016,994	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.35680	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.33780	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.30540	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$20,568,182	OtherCostOrOtherBasisAmt
Depreciation	$11,793,845	DepreciationAmt
Book Value	$8,774,337	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$11,542,084	OtherCostOrOtherBasisAmt
Depreciation	$9,301,338	DepreciationAmt
Book Value	$2,240,746	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$3,615,436	OtherCostOrOtherBasisAmt
Depreciation	$2,752,314	DepreciationAmt
Book Value	$863,122	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$11,878,205	TotalBookValueLandBuildingsAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART V, LINE 4:	FormAndLineReferenceDesc
Explanation	IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY, PATH UTILIZES THE INCOME EARNED ON THE ENDOWMENT FUNDS AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (53 entries)

RegionRegionTxt	OfficesOfficesCnt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$3,280
CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$100,574
CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$9,576
CENTRAL AMERICA AND THE CARIBBEAN	0	0	GRANTMAKING		$422,051
EAST ASIA AND THE PACIFIC	4	98	MANAGEMENT & GENERAL		$2,407,089
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$449,523
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	INTERNATIONAL DEVELOPMENT	$3,111,637
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$162,346
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$95,001
EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	OTHER	$28,825
EAST ASIA AND THE PACIFIC	0	0	FUNDRAISING		$1,062
EAST ASIA AND THE PACIFIC	0	0	GRANTMAKING		$5,776,709
EUROPE	2	7	MANAGEMENT & GENERAL		$229,292
EUROPE	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$5,966,007
EUROPE	0	0	PROGRAM SERVICES	INTERNATIONAL DEVELOPMENT	$182,294
EUROPE	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$2,648,143
EUROPE	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$202,554
EUROPE	0	0	PROGRAM SERVICES	OTHER	$74,767
EUROPE	0	0	FUNDRAISING		$7,895
EUROPE	0	0	GRANTMAKING		$17,663,718
MIDDLE EAST AND NORTH AFRICA	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$9,566
NORTH AMERICA	0	0	MANAGEMENT & GENERAL		$48,338
NORTH AMERICA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$89,918
NORTH AMERICA	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$256,241
NORTH AMERICA	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$1,882
NORTH AMERICA	0	0	PROGRAM SERVICES	OTHER	$15
NORTH AMERICA	0	0	GRANTMAKING		$723,170
RUSSIA AND NEIGHBORING STATES	1	21	MANAGEMENT & GENERAL		$708,047
RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$4,706
RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	INTERNATIONAL DEVELOPMENT	$1,856,330
RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$6,388
RUSSIA AND NEIGHBORING STATES	0	0	GRANTMAKING		$304,185
SOUTH AMERICA	1	3	MANAGEMENT & GENERAL		$129,338
SOUTH AMERICA	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$308,163
SOUTH AMERICA	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$10,498
SOUTH AMERICA	0	0	PROGRAM SERVICES	OTHER	$1,390
SOUTH AMERICA	0	0	GRANTMAKING		$32,395
SOUTH ASIA	3	80	MANAGEMENT & GENERAL		$2,434,350
SOUTH ASIA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$234,365
SOUTH ASIA	0	0	PROGRAM SERVICES	INTERNATIONAL DEVELOPMENT	$1,721,672
SOUTH ASIA	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$1,296,409
SOUTH ASIA	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$396,469
SOUTH ASIA	0	0	PROGRAM SERVICES	OTHER	$127,028
SOUTH ASIA	0	0	FUNDRAISING		$377
SOUTH ASIA	0	0	GRANTMAKING		$3,231,753
SUB-SAHARAN AFRICA	38	884	MANAGEMENT & GENERAL		$17,028,617
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	$847,531
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	INTERNATIONAL DEVELOPMENT	$24,526,813
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	PUBLIC HEALTH	$27,174,164
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	$424,515
SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	OTHER	$1,535,589
SUB-SAHARAN AFRICA	0	0	FUNDRAISING		$9,265
SUB-SAHARAN AFRICA	0	0	GRANTMAKING		$11,287,145

Field	Value	IRS element (for citing)
Subtotal Offices	4	SubtotalOfficesCnt
Subtotal Employees	98	SubtotalEmployeesCnt
Continuation Total Office	45	ContinuationTotalOfficeCnt
Continuation Total Employee	995	ContinuationTotalEmployeeCnt
Total Office	49	TotalOfficeCnt
Total Employee	1093	TotalEmployeeCnt
Subtotal Spent	$6,666,076	SubtotalSpentAmt
Continuation Spent	$129,642,899	ContinuationSpentAmt
Total Spent	$136,308,975	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (237 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
CENTRAL AMERICA & THE CARIBBEAN	PUBLIC HEALTH	$111,404	CHECK/WIRE
CENTRAL AMERICA & THE CARIBBEAN	PUBLIC HEALTH	$120,647	CHECK/WIRE
CENTRAL AMERICA & THE CARIBBEAN	PUBLIC HEALTH	$190,000	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$189,195	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,680	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$892,512	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$49,773	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$134,235	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$22,032	CHECK/WIRE
EAST ASIA & THE PACIFIC	PUBLIC HEALTH	$55,000	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,306	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$303,016	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,800	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,880	CHECK/WIRE
EAST ASIA & THE PACIFIC	PUBLIC HEALTH	$31,000	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$29,170	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$450,000	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,800	CHECK/WIRE
EAST ASIA & THE PACIFIC	PUBLIC HEALTH	$24,589	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$54,807	CHECK/WIRE
EAST ASIA & THE PACIFIC	PUBLIC HEALTH	$10,000	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$66,356	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$296,299	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$6,113	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$329,549	CHECK/WIRE
EAST ASIA & THE PACIFIC	OTHER	$33,622	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$295,675	CHECK/WIRE
EAST ASIA & THE PACIFIC	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$165,701	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,888	CHECK/WIRE
EAST ASIA & THE PACIFIC	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$34,925	CHECK/WIRE
EAST ASIA & THE PACIFIC	ESSENTIAL MEDICINE	$2,130,300	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$28,679	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,820	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,028	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$5,240	CHECK/WIRE
EAST ASIA & THE PACIFIC	INTERNATIONAL DEVELOPMENT	$88,919	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$96,699	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$7,948	CHECK/WIRE
EUROPE	OTHER	$6,269	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$144,679	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$272,930	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$12,551	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$79,864	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$8,696,269	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$805,955	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$42,754	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$245,349	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$29,565	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$23,144	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$77,920	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$132,952	CHECK/WIRE
EUROPE	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$266,707	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$7,040	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$766,955	CHECK/WIRE
EUROPE	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$128,329	CHECK/WIRE
EUROPE	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$198,213	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$597,961	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$1,924,141	CHECK/WIRE
EUROPE	OTHER	$2,037,468	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$68,674	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$350,000	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$89,906	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	$524,276	CHECK/WIRE
EUROPE	PUBLIC HEALTH	$36,173	CHECK/WIRE
NORTH AMERICA	OTHER	$14,645	CHECK/WIRE
NORTH AMERICA	PUBLIC HEALTH	$10,690	CHECK/WIRE
NORTH AMERICA	ESSENTIAL MEDICINE	$697,836	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$20,705	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$58,639	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$17,050	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$19,876	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$66,652	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$15,395	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$30,153	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$15,489	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$8,531	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$18,645	CHECK/WIRE
RUSSIA & NEIGHBORING STATES	INTERNATIONAL DEVELOPMENT	$31,193	CHECK/WIRE
SOUTH AMERICA	PUBLIC HEALTH	$42,173	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$13,676	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$124,626	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$195,977	CHECK/WIRE
SOUTH ASIA	INTERNATIONAL DEVELOPMENT	$948,739	CHECK/WIRE
SOUTH ASIA	OTHER	$39,117	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$12,990	CHECK/WIRE
SOUTH ASIA	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$15,387	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	$139,763	CHECK/WIRE
SOUTH ASIA	PUBLIC HEALTH	$359,063	CHECK/WIRE
SOUTH ASIA	INTERNATIONAL DEVELOPMENT	$1,028,551	CHECK/WIRE
SOUTH ASIA	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$10,000	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	$343,866	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$52,379	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$29,720	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$301,502	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$20,367	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$37,658	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,754	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,991	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,767	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,507	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$22,742	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$94,104	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,325	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$56,540	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	$3,075,203	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$19,852	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$154,139	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$22,013	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,933	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$21,882	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,521	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$14,005	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,284	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$77,168	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,747	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$572,495	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$43,423	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$246,432	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$96,421	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$33,000	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$211,704	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,723	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$61,821	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,517	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,583	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$48,783	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$181,927	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$7,350	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$65,011	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$397,845	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,100	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	$46,040	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$146,086	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$606,616	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	$27,545	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$12,054	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,939	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,389	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$237,066	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$29,292	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$9,091	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$281,816	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$87,415	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$36,144	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$34,348	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$25,929	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$34,494	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,060	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$42,302	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$95,994	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$38,012	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,703	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$47,729	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$31,275	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$30,488	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$33,141	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$29,239	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$33,534	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$38,899	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,692	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$88,956	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	$367,647	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$297,207	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,618	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$48,437	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$15,681	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$22,156	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$15,000	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$16,166	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$25,392	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$23,685	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,981	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$40,887	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,479	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,408	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$104,715	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$13,138	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,579	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	$5,037	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,751	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$5,352	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,801	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$95,373	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,943	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$23,596	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,928	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$27,405	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$45,150	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,007	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$70,016	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$235,598	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$9,401	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$16,699	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$48,940	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,903	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,401	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$28,074	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	$8,310	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$17,912	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$12,114	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$23,122	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,587	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,755	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$45,181	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$35,183	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$12,062	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$13,786	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,676	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,459	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY, DEVELOPMENT, & INTRODUCTION	$11,000	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$14,709	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$12,759	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$11,208	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$35,066	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$85,000	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$25,448	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$48,239	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$11,818	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,986	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$8,206	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$30,666	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$12,473	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$13,414	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$47,652	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$7,732	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$88,118	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$14,437	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,685	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$255,061	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$20,559	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$18,712	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$24,091	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$9,855	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$24,379	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$25,160	CHECK/WIRE
SUB-SAHARAN AFRICA	PUBLIC HEALTH	$35,506	CHECK/WIRE
SUB-SAHARAN AFRICA	INTERNATIONAL DEVELOPMENT	$10,776	CHECK/WIRE

Field	Value	IRS element (for citing)
Total501c3 Org	194	Total501c3OrgCnt
Total Other Org	40	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE THAT GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE REASONABLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (77 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
APPALACHIAN STATE UNIVERSITY
287 RIVERS STREET SUITE 382	BOONE	NC	286082174	561176030	GOV	$90,702	ESSENTIAL MEDICINE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
ACCOUNTING DEPARTMENT MLC 4900 3333	CINCINNATI	OH	45229	310833936	501(C)(3)	$529,934	ESSENTIAL MEDICINE	BURNE
DUKE UNIVERSITY
2200 WEST MAIN STREET SUITE 910B	DURHAM	NC	27710	560532129	501(C)(3)	$231,253	ESSENTIAL MEDICINE
FINA BIOSOLUTIONS LLC
9430 KEY WEST AVE SUITE 200	ROCKVILLE	MD	20850	205448275	N/A	$186,314	ESSENTIAL MEDICINE
FOOD & DRUG ADMINISTRATION
10903 NEW HAMPSHIRE AVENUE	SILVER SPRING	MD	20993	530196965	GOV	$497,750	ESSENTIAL MEDICINE
FRAUNHOFER USA CENTER FOR MOLECULAR BIOTECHNOLOGY
9 INNOVATION WAY SUITE 200	NEWARK	DE	19711	383203030	501(C)(3)	$598,805	ESSENTIAL MEDICINE
HARVARD COLLEGE PRESIDENT & FELLOWS OF
1350 MASSACHUSETTS AVENUE SMITH	CAMBRIDGE	MA	02138	042103580	501(C)(3)	$263,270	ESSENTIAL MEDICINE	CAMPUS CENTER 727
HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE
4301 JONES BRIDGE ROAD ROOM G074	BETHESDA	MD	20814	521317896	501(C)(3)	$20,700	ESSENTIAL MEDICINE
INTERNATIONAL AIDS VACCINE INITIATIVE
110 WILLIAM ST 27TH FLOOR	NEW YORK	NY	10038	133870223	501(C)(3)	$92,075	ESSENTIAL MEDICINE
INVENTPRISE LLC
18133 NE 68TH STREET SUITE D150	REDMOND	WA	98052	454927373	N/A	$1,253,887	ESSENTIAL MEDICINE
JOHNS HOPKINS UNIVERSITY
OFFICE OF RESEARCH ADMINISTRATION	BALTIMORE	MD	21205	131687001	501(C)(3)	$324,031	ESSENTIAL MEDICINE	615 N WOLFE STREET W1100
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET	BOSTON	MA	02114	041564655	501(C)(3)	$65,000	ESSENTIAL MEDICINE
MASSBIOLOGICS INC
460 WALK HILL STREET	BOSTON	MA	02126	010621493	501(C)(3)	$146,175	ESSENTIAL MEDICINE
NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
6610 ROCKLEDGE DRIVE MSC 6612	BETHESDA	MD	208926612	520858115	GOV	$996,233	ESSENTIAL MEDICINE
PAN AMERICAN HEALTH ORGANIZATION
525 TWENTY-THIRD STREET NW	WASHINGTON	DC	20037	237072046	501(C)(3)	$19,983	ESSENTIAL MEDICINE
SABIN VACCINE INSTITUTE
2175 K STREET NW SUITE 400	WASHINGTON	DC	20037	061389829	501(C)(3)	$35,000	ESSENTIAL MEDICINE
SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORRY PINES ROAD	LA JOLLA	CA	92037	330435954	501(C)(3)	$560,808	ESSENTIAL MEDICINE
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N SUITE 500	SEATTLE	WA	981095219	910961784	501(C)(3)	$2,053,575	ESSENTIAL MEDICINE
STATE UNIVERSITY OF NEW YORK AT BUFFALO
1300 ELWOOD AVENUE	BUFFALO	NY	14222	160865182	501(C)(3)	$160,926	ESSENTIAL MEDICINE
UNITED STATES NAVAL MEDICAL RESEARCH CENTER
503 ROBERT GRANT AVE	SILVER SPRING	MD	209107500	470100048	GOV	$132,723	ESSENTIAL MEDICINE
UNIVERSITY OF ALABAMA AT BIRMINGHAM
701 20TH STREET SOUTH AB 1170	BIRMINGHAM	AL	35294	636005396	501(C)(3)	$265,958	ESSENTIAL MEDICINE
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE CENTER FOR VACCINE DEVELOPMENT
685 WEST BALTIMORE ST RM 480	BALTIMORE	MD	21201	526002033	501(C)(3)	$252,267	ESSENTIAL MEDICINE
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTH S4-110	WORCESTER	MA	01655	043167352	GOV	$10,000	ESSENTIAL MEDICINE
UNIVERSITY OF TEXAS AUSTIN
3925 W BRAKER LN BLDG 159 STE	AUSTIN	TX	787595316	746000203	GOV	$100,000	ESSENTIAL MEDICINE	311072
UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE
85 SOUTH PROSPECT STREET WATERMAN	BURLINGTON	VT	05405	030179440	501(C)(3)	$51,861	ESSENTIAL MEDICINE	217
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE BOX 359472	SEATTLE	WA	98195	916001537	501(C)(3)	$407,842	ESSENTIAL MEDICINE
WALTER REED ARMY INSTITUTE OF RESEARCH
503 ROBERT GRANT AVENUE	SILVER SPRING	MD	209107500	520664528	GOV	$3,122,830	ESSENTIAL MEDICINE
YALE UNIVERSITY
GRANTS CONTRACT FINANCIAL ADMIN PO	NEW HAVEN	CT	065081873	060646973	501(C)(3)	$259,361	ESSENTIAL MEDICINE	BOX 1873
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION
1140 CONNECTICUT AVENUE NW	WASHINGTON	DC	20036	954191698	501(C)(3)	$71,163	INTERNATIONAL DEVELOPMENT
INITIATIVES INC
264 BEACON STREET	BOSTON	MA	02116	042961350	N/A	$418,081	INTERNATIONAL DEVELOPMENT
WORLD VISION DC
300 I STREET NE	WASHINGTON	DC	20002	951922279	501(C)(3)	$2,761,066	INTERNATIONAL DEVELOPMENT
AMERICAN ACADEMY OF PEDIATRICS
141 NORTHWEST POINT BLVD ELK GROVE	ELK GROVE VILLAGE	IL	600071098	362275597	501(C)(3)	$37,434	OTHER	VILLAGE
DEVEX
1341 CONNECTICUT AVE NW	WASHINGTON	DC	20036	043524272	N/A	$136,500	OTHER
GLOBAL HEALTH VISIONS
138 BROADWAY SUITE 1G	BROOKLYN	NY	11211	261903904	N/A	$41,372	OTHER
THE NATIONAL ACADEMIES OF SCIENCES ENGINEERING AND MEDICINE
500 5TH ST NW	WASHINGTON	DC	200012736	530196932	501(C)(3)	$20,000	OTHER
ACESO GLOBAL
1400 16TH ST NW STE 430	WASHINGTON	DC	200362239	474215911	501(C)(3)	$149,910	PUBLIC HEALTH
AMREF HEALTH AFRICA INC
4 WEST 43RD STREET 2ND FLOOR	NEW YORK	NY	10036	131867411	501(C)(3)	$25,080	PUBLIC HEALTH
BASIC HEALTH INTERNATIONAL INC
25 BROADWAY 9TH FLOOR	NEW YORK	NY	10004	203408717	501(C)(3)	$90,000	PUBLIC HEALTH
BRAC USA
110 WILLIAM ST FL 29	NEW YORK	NY	100383901	208456741	501(C)(3)	$55,784	PUBLIC HEALTH
BRIGHAM AND WOMEN'S HOSPITAL
651 HUNTINGTON AVE FXB BUILDING	BOSTON	MA	02115	042312909	501(C)(3)	$315,011	PUBLIC HEALTH
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION
1140 CONNECTICUT AVENUE NW	WASHINGTON	DC	20036	954191698	501(C)(3)	$222,972	PUBLIC HEALTH
EVIDENCE ACTION
641 S ST NW FL WEWORK	WASHINGTON	DC	200015196	900874591	501(C)(3)	$67,348	PUBLIC HEALTH
FAMILY HEALTH INTERNATIONAL 360
FHI 360 HEADQUARTERS 359 BLACKWELL	DURHAM	NC	27701	237413005	501(C)(3)	$294,444	PUBLIC HEALTH	ST SUITE 200
GLOBAL HEALTH CORPS
111 STREET	NEW YORK	NY	10001	800512336	501(C)(3)	$5,100	PUBLIC HEALTH
GYNUITY HEALTH PROJECTS LLC
15 EAST 26TH STREET SUITE 801	NEW YORK	NY	10010	061652595	N/A	$11,771	PUBLIC HEALTH
HARVARD UNIVERSITY SCHOOL OF PUBLIC HEALTH
INTERNATIONAL HEALTH 677 HUNTINGTON	BOSTON	MA	02115	042103580	501(C)(3)	$25,000	PUBLIC HEALTH	AVENUE
HEALTH ALLIANCE INTERNATIONAL
4534 11TH AVE NE	SEATTLE	WA	98105	943047981	501(C)(3)	$56,464	PUBLIC HEALTH
HELEN KELLER INTERNATIONAL
352 PARK AVENUE SOUTH 12TH FLOOR	NEW YORK	NY	10010	135562162	501(C)(3)	$90,644	PUBLIC HEALTH
ICAPCOLUMBIA UNIVERSITY
SPONSORED PROJECT ADMIN 722 WEST	NEW YORK	NY	10032	135598093	501(C)(3)	$366,037	PUBLIC HEALTH	168TH ST 13TH FLOOR
INTRAHEALTH INTERNATIONAL
6340 QUADRANGLE DRIVE SUITE 200	CHAPEL HILL	NC	27514	550825466	501(C)(3)	$404,921	PUBLIC HEALTH
IPAS
PO BOX 9990	CHAPEL HILL	NC	275151990	561071085	501(C)(3)	$21,062	PUBLIC HEALTH
JSI RESEARCH & TRAINING INSTITUTE INC
1616 NORTH FORT MYER 16TH FLOOR	ARLINGTON	VA	22209	042578579	N/A	$309,102	PUBLIC HEALTH
KYBELE INC
3524 YADKINVILLE ROAD 124	WINSTON SALEM	NC	27106	900759003	501(C)(3)	$193,321	PUBLIC HEALTH
MEDICAL CARE DEVELOPMENT INC
8401 COLESVILLE ROAD SUITE 425	SILVER SPRING	MD	20910	016022787	501(C)(3)	$1,487,876	PUBLIC HEALTH
PATHFINDER INTERNATIONAL
NINE GALEN STREET SUITE 217	WATERTOWN	MA	02472	530235320	501(C)(3)	$104,055	PUBLIC HEALTH
POPULATION COUNCIL
ONE DAG HAMMARSKJOLD PLAZA 3RD FL	NEW YORK	NY	10017	131687001	501(C)(3)	$89,094	PUBLIC HEALTH
POPULATION SERVICES INTERNATIONAL
1120 19TH STREET NW SUITE 600	WASHINGTON	DC	20036	560942853	501(C)(3)	$816,484	PUBLIC HEALTH
QUALIS HEALTH
10700 MERIDIAN AVE N 100	SEATTLE	WA	98133	911072875	501(C)(3)	$270,182	PUBLIC HEALTH
RESULTS FOR DEVELOPMENT INSTITUTE INC
1111 19TH ST NW SUITE 700	WASHINGTON	DC	20036	208530747	501(C)(3)	$522,450	PUBLIC HEALTH
SAVE THE CHILDREN FEDERATION INC
2000 L ST NW STE 500	WASHINGTON	DC	200364938	060726487	501(C)(3)	$447,970	PUBLIC HEALTH
SYSTMAPP INC
2000 TOWN CENTER SUITE 300	SOUTHFIELD	MI	48075	812936844	N/A	$399,200	PUBLIC HEALTH
TULANE EDUCATIONAL FUND
1430 TULANE AVENUE TB-32	NEW ORLEANS	LA	701122632	720423889	501(C)(3)	$14,395	PUBLIC HEALTH
TULANE UNIVERSITY SCHOOL OF PUBLIC HEALTH AND TROPICAL MEDICINE
1440 CANAL ST	NEW ORLEANS	LA	70112	720423889	501(C)(3)	$217,741	PUBLIC HEALTH
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE BOX 359472	SEATTLE	WA	98195	916001537	501(C)(3)	$278,122	PUBLIC HEALTH
VILLAGEREACH
2900 EASTLAKE AVE E STE 230	SEATTLE	WA	981023012	912083484	501(C)(3)	$34,490	PUBLIC HEALTH
BECTON DICKINSON
1 BECTON DR	FRANKLIN LAKES	NJ	074171815		N/A	$2,054,211	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
CASCADE DESIGNS INC
4000 FIRST AVENUE SOUTH	SEATTLE	WA	98134	910969695	N/A	$274,540	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
CONDUCTIVE TECHNOLOGIES INC
935 BOROM RD	YORK	PA	174041382	233039618	N/A	$79,000	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
HEIFER INTERNATIONAL DC
1112 16TH ST NW SUITE 500	WASHINGTON	DC	20036	351019477	501(C)(3)	$10,000	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	981050371	910564748	501(C)(3)	$46,315	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
UNIVERSITY OF TENNESSEE
1534 WHITE AVENUE ROOM A004 BLOUNT	KNOXVILLE	TN	379961529	626001636	GOV	$51,730	TECHNOLOGY, DEVELOPMENT & INTRODUCTION	HALL
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE BOX 359472	SEATTLE	WA	98195	916001537	501(C)(3)	$1,072,353	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
VAYU US INC
847 WILLOW RUN AIRPORT	YPSILANTI	MI	481980899	465737909	N/A	$65,000	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
PATH DRUG SOLUTIONS
2201 WESTLAKE AVE SUITE 200	SEATTLE	WA	98121	943384500	501(C)(3)	$146,405	OTHER
UNITED NATIONS FUND FOR POPULATION ACTIVITIES
223 EAST 42ND STREET	NEW YORK	NY	10017		GOV	-$42,937	PUBLIC HEALTH
OVERLAKE HOSPITAL MEDICAL CENTER
1037 116TH AVE NE	BELLEVUE	WA	98004	910652651	501(C)(3)	-$26,320	TECHNOLOGY, DEVELOPMENT & INTRODUCTION
SOLAR ELECTRIC LIGHT FUND
1612 K STREET NW SUITE 300	WASHINGTON	DC	20006	521701564	501(C)(3)	-$17,795	TECHNOLOGY, DEVELOPMENT & INTRODUCTION

Field	Value	IRS element (for citing)
Total501c3 Org	59	Total501c3OrgCnt
Total Other Org	12	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE REASONABLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Idemnification Gross Up Pmts	Yes (X)	IdemnificationGrossUpPmtsInd
Housing Allowance Or Residence	Yes (X)	HousingAllowanceOrResidenceInd
Written Policy Ref T And E Expnss	Yes (1)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (1)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEPHEN B DAVIS
PRESIDENT AND CEO	$486,134	$0	$147,638	$0	$7,750	$0	$32,200	$0	$33,584	$0	$707,306	$0	$0	$0
OLIVIA D POLIUS
CHIEF FINANCIAL OFFICER	$309,227	$0	$0	$0	$2,100	$0	$32,400	$0	$20,704	$0	$364,431	$0	$0	$0
DANIEL LASTER
COO AND GENERAL COUNSEL	$332,258	$0	$0	$0	$1,800	$0	$32,400	$0	$8,618	$0	$375,076	$0	$0	$0
DAVID C KASLOW
VP - PRODUCT DEVELOPMENT	$358,097	$0	$0	$0	$9,910	$0	$32,400	$0	$35,308	$0	$435,715	$0	$0	$0
AMIE E BATSON
CHIEF STRATEGY OFFICER	$301,024	$0	$0	$0	$11,807	$0	$26,579	$0	$816	$0	$340,226	$0	$0	$0
KATHY CAHILL
VP - INTERNATIONAL DEVELOPMENT	$284,829	$0	$0	$0	$0	$0	$32,335	$0	$5,576	$0	$322,740	$0	$0	$0
DAVID W FLEMING
VP - PUBLIC HEALTH	$274,501	$0	$0	$0	$0	$0	$32,400	$0	$16,240	$0	$323,141	$0	$0	$0
KATHRYN A O'DRISCOLL
CHIEF HUMAN RESOURCES OFFICER	$241,836	$0	$0	$0	$1,800	$0	$27,388	$0	$17,344	$0	$288,368	$0	$0	$0
MARK D MURRAY
VP - GLOBAL ENGAGEMENT	$265,839	$0	$0	$0	$0	$0	$32,385	$0	$19,893	$0	$318,117	$0	$0	$0
JEFFREY D BERSON
DIRECTOR	$177,948	$0	$0	$0	$277,714	$0	$22,976	$0	$26,213	$0	$504,851	$0	$0	$0
JAMES B MCKENNA
ASSOCIATE DIRECTOR	$137,865	$0	$0	$0	$294,239	$0	$20,932	$0	$49,230	$0	$502,266	$0	$0	$0
RIKKA E TRANGSRUD
COUNTRY PROGRAM LEADER	$162,618	$0	$0	$0	$214,205	$0	$20,239	$0	$22,405	$0	$419,467	$0	$0	$0
TRAD M HATTON
CHIEF OF PARTY	$125,324	$0	$0	$0	$187,522	$0	$16,650	$0	$26,013	$0	$355,509	$0	$0	$0
BRUCE LAMONT INNIS
GLOBAL DISEASE AREA HEAD	$259,770	$0	$0	$0	$50,700	$0	$19,095	$0	$1,709	$0	$331,274	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 1A	HOUSING ALLOWANCES & TAX INDEMNIFICATIONS ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITIONS. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT.
PART I, LINE 7	BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	ALTIMETRIK CORPORATION	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Relationship Description	ALTIMETRIK IS CONTR	RelationshipDescriptionTxt
Transaction	$103,000	TransactionAmt
Transaction	PATH PURCHA	TransactionDesc
Sharing Of Revenues	0	SharingOfRevenuesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS:	FormAndLineReferenceDesc
Explanation	(A) NAME OF INTERESTED PERSON: ALTIMETRIK CORPORATION(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: ALTIMETRIK IS CONTROLLED BY RAJENDRA VATTIKUTI, PATH BOARD MEMBER (NOTE: RAJ'S SERVICE ON PATH'S BOARD CONCLUDED ON DECEMBER, 2017)(D) DESCRIPTION OF TRANSACTION: PATH PURCHASED SERVICES FROM ALTIMETRIK DURING THE YEAR.	ExplanationTxt

Schedule M IRS990ScheduleM

Cars And Other Vehicles CarsAndOtherVehiclesGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	1	ContributionCnt
Noncash Contributions Rpt F990	$15,247	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FMV	MethodOfDeterminingRevenuesTxt

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	22	ContributionCnt
Noncash Contributions Rpt F990	$136,150	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FMV	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, COLUMN (B):	FormAndLineReferenceDesc
Explanation	THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART I, LINE 1	PATH IS A GLOBAL ORGANIZATION THAT WORKS TO ELIMINATE HEALTH INEQUITIES BY BRINGING TOGETHER INSTITUTIONS, BUSINESSES, INVESTORS, AND INDIVIDUALS TO SOLVE THE WORLD'S MOST PRESSING HEALTH CHALLENGES. WITH EXPERTISE IN SCIENCE, MARKET DEVELOPMENT, TECHNOLOGY, ADVOCACY, AND DOZENS OF OTHER SPECIALTIES, PATH DEVELOPS AND SCALES SOLUTIONS-INCLUDING VACCINES, DRUGS, DEVICES, DIAGNOSTICS, AND INNOVATIVE APPROACHES TO STRENGTHENING HEALTH SYSTEMS WORLDWIDE. SINCE 2011, PATH AND OUR PARTNERS AND SUPPORTERS HAVE REACHED AN AVERAGE OF 150 MILLION PEOPLE PER YEAR WITH LIFESAVING HEALTH SOLUTIONS.
FORM 990, PART III, LINE 4B	MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION PATH WORKS WITH PARTNERS TO IMPROVE MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION AROUND THE WORLD. TOGETHER WE DEVELOP, ADAPT, AND SCALE TECHNOLOGIES AND APPROACHES TO REDUCE ILLNESS AND DEATH AND GIVE CHILDREN THE BEST POSSIBLE START IN LIFE. IN ALL OUR EFFORTS, WE PUT THE LOCAL GOVERNMENT IN THE DRIVER'S SEAT TO ENSURE BOTH SCALE AND SUSTAINABILITY. IN 2017, PATH CONTINUED TO EXPAND OUR LEADERSHIP IN EARLY CHILDHOOD DEVELOPMENT (ECD). WITH PATH SUPPORT, THE GOVERNMENTS OF KENYA AND MOZAMBIQUE WORKED TO INCORPORATE ECD SERVICES INTO BASIC HEALTH CARE FOR CAREGIVERS AND YOUNG CHILDREN. PATH'S APPROACH TO INTEGRATING ECD INTO THE HEALTH SYSTEM FOCUSES ON SUPPORTING AND BUILDING THE CAPACITY OF EXISTING HEALTH SERVICE PROVIDERS AND THEIR SUPERVISORS. IN ADDITION, PATH CONTINUED TO SUPPORT A PROJECT KNOWN AS MAXIMIZING THE QUALITY OF SCALING UP NUTRITION PLUS (MQSUN+). IN THIS PROJECT, PATH LEADS A CONSORTIUM OF FIVE ORGANIZATIONS THAT ARE EXPANDING THE EVIDENCE BASE ON THE CAUSES OF UNDERNUTRITION, ENHANCING THE SKILLS AND CAPACITY OF PARTICIPATING GOVERNMENTS TO SCALE UP NUTRITION-RELATED PROGRAMS AND POLICIES, AND PROVIDING TECHNICAL GUIDANCE ON PROGRAM DESIGN, IMPLEMENTATION, AND MONITORING AND EVALUATION. PATH ALSO CONTINUED EFFORTS TO SCALE UP USE OF HUMAN MILK BANKS SO NEWBORNS AND INFANTS CAN BENEFIT FROM BREAST MILK EVEN WHEN THEIR MOTHERS ARE UNABLE TO BREASTFEED. MILK BANKS USE DONATED EXTRA MILK FROM LACTATING MOTHERS, PASTEURIZE IT TO MAKE IT SAFE, AND FREEZE IT UNTIL IT IS NEEDED. IN GHANA, THE MAKING EVERY BABY COUNT INITIATIVE STRENGTHENS LEADERSHIP AND CAPACITY AT THE NATIONAL AND LOCAL LEVELS TO MANAGE AND SUSTAIN BEST PRACTICES IN NEWBORN CARE. IN 2017, PATH SUPPORTED GHANA'S CENTRAL GOVERNMENT AND REGIONS TO REDUCE NEONATAL MORTALITY THROUGH SPECIFIC ACTIVITIES THAT IMPROVED AND STANDARDIZED NEWBORN CARE. SEXUAL AND REPRODUCTIVE HEALTH PATH'S WORK IN SEXUAL AND REPRODUCTIVE HEALTH IS GUIDED BY THE KEY PRINCIPLES OF CHOICE, EQUITY, AND DIGNITY FOR ALL WOMEN. BECAUSE WE UNDERSTAND THE COMPLEX SOCIAL, BEHAVIORAL, AND GENDER DIMENSIONS OF WOMEN'S REPRODUCTIVE HEALTH, WE BUILD EVIDENCE AROUND TOOLS AND SERVICES THAT ARE BEST SUITED TO ADDRESS WOMEN'S DIVERSE NEEDS AND CIRCUMSTANCES. WE SPECIALIZE IN REDUCING BARRIERS TO ACCESS. PATH CONTINUES TO CHAMPION WOMEN'S RIGHT TO MANAGE THEIR OWN SEXUAL AND REPRODUCTIVE HEALTH NEEDS BY CREATING AND ADVANCING IMPROVED TOOLS AND PRACTICES THAT MAKE WOMEN'S SELF-CARE POSSIBLE. AN INTEGRATED APPROACH TO WOMEN'S HEALTH INCLUDES ATTENTION TO CONTRACEPTION, CERVICAL CANCER, SEXUALLY TRANSMITTED INFECTIONS, THE RIGHT TO DECIDE WHETHER AND WHEN THEY WANT TO BECOME MOTHERS, AND GENDER-BASED VIOLENCE PREVENTION AND CARE SERVICES. WE SPEARHEAD DISCUSSIONS OF THE PRACTICES, BEHAVIORS, AND TOOLS THAT ENABLE WOMEN TO SELF-ASSESS AND SELF-MANAGE THEIR SEXUAL AND REPRODUCTIVE HEALTH NEEDS. AMONG THE RECENT WOMAN-INITIATED PRODUCTS INTRODUCED IN OUR PROJECTS ARE AN ALL-IN-ONE INJECTABLE CONTRACEPTIVE THAT CAN BE SELF-ADMINISTERED AND A VAGINAL SELF-SAMPLING KIT FOR HUMAN PAPILLOMAVIRUS (HPV) TESTING IN CERVICAL CANCER SCREENING PROGRAMS. IN 2017, WE CONCLUDED COUNTRY-LED PILOT INTRODUCTIONS OF A NEW FORM OF INJECTABLE CONTRACEPTION, SUBCUTANEOUS DEPOT MEDROXYPROGESTERONE ACETATE (DMPA-SC, SOLD BY PFIZER INC. AS SAYANA PRESS). THIS PRODUCT COMBINES A LOWER-DOSE FORMULATION OF THE WIDELY USED CONTRACEPTIVE DEPO-PROVERA WITH THE PATH-DEVELOPED UNIJECT INJECTION SYSTEM. DURING THE PILOT PERIOD, NEARLY HALF A MILLION UNITS WERE ADMINISTERED IN BURKINA FASO, NIGER, SENEGAL, AND UGANDA. DMPA-SC WAS ADMINISTERED TO APPROXIMATELY 135,000 WOMEN USING MODERN CONTRACEPTION FOR THE FIRST TIME. THE SUCCESS OF THESE PILOTS MEANT THAT ALL FOUR COUNTRIES BEGAN MOVING FORWARD WITH PRODUCT SCALE-UP OR EXPANSION IN THEIR NATIONAL FAMILY PLANNING PROGRAMS. PATH ALSO COMPLETED RESEARCH ON SELF-INJECTION OF DMPA-SC IN SENEGAL AND UGANDA. THESE STUDIES, CO-LED BY THE SENEGAL AND UGANDA MINISTRIES OF HEALTH, LED TO GOVERNMENT DECISIONS TO PILOT SELF-INJECTION OUTSIDE OF A RESEARCH SETTING IN BOTH COUNTRIES. IN ADDITION, PATH WORKED WITH PARTNERS WORLDWIDE AND IN SEVERAL COUNTRIES TO IMPROVE THE PREVENTION, DETECTION, AND TREATMENT OF CERVICAL CANCER, WHICH IS MOST OFTEN CAUSED BY INFECTION WITH HPV. WE PARTNERED WITH COMPANIES TO DEVELOP NEW DEVICES TO IMPROVE PRECANCER TREATMENT IN LOW- AND MIDDLE-INCOME COUNTRIES. WE ALSO PARTNERED WITH THE MINISTRIES OF HEALTH IN GUATEMALA, HONDURAS, AND NICARAGUA TO INTRODUCE AND QUICKLY SCALE UP HPV TESTING FOR PRIMARY CERVICAL CANCER SCREENING. THIS METHOD ENABLES WOMEN TO COLLECT THEIR OWN SAMPLES FOR SCREENING, REDUCING BOTTLENECKS IN THE HEALTH CARE SYSTEM AND OVERCOMING CULTURAL BARRIERS TO INTIMATE EXAMS. TO COMBAT BREAST CANCER, WE WORKED WITH THE NATIONAL CANCER INSTITUTE IN PERU TO DEVELOP MATERIALS FOR TRAINING NURSES AND VOLUNTEERS TO SERVE AS PATIENT NAVIGATORS FOR WOMEN AND THEIR FAMILIES. PATH ALSO CONTINUED TO SERVE AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF MORE THAN 400 PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCY AND SEXUALLY TRANSMITTED INFECTIONS. DIGITAL HEALTH SOLUTIONS PATH USES INFORMATION AND COMMUNICATION TECHNOLOGIES TO IMPROVE HEALTH AND SAVE LIVES. IN 2017, OUR GROWING DIGITAL HEALTH TEAM APPLIED ITS EXPERTISE TO AN INCREASING NUMBER OF PROJECTS. KEY ACCOMPLISHMENTS INCLUDED LAUNCHING PHASE 2 OF THE DATA USE PARTNERSHIP, WHICH SUPPORTS THE GOVERNMENT OF TANZANIA TO IMPROVE COUNTRYWIDE HEALTH INFORMATION SYSTEMS AND IMPLEMENT ITS DIGITAL HEALTH INVESTMENT ROAD MAP. WE ALSO CONTINUED WORK UNDER DIGITAL SQUARE, A PATH-LED INITIATIVE. THIS IS A PARTNERSHIP OF THE WORLD'S LEADING DIGITAL HEALTH EXPERTS FROM MORE THAN 40 ORGANIZATIONS AND COUNTRIES WORKING TOGETHER TO STRENGTHEN DIGITAL HEALTH SYSTEMS IN EMERGING ECONOMIES. IN ADDITION, WE COLLABORATED WITH THE JOINT LEARNING NETWORK FOR UNIVERSAL HEALTH COVERAGE TO LAUNCH A NEW PEER LEARNING NETWORK THAT INCLUDES PROFESSIONALS FROM MINISTRIES OF HEALTH AND NATIONAL HEALTH INSURANCE AGENCIES IN TEN COUNTRIES. THESE PROFESSIONALS ARE WORKING TO IMPROVE THEIR HEALTH CARE DATA SYSTEMS, WHICH WILL HELP THEIR COUNTRIES ACHIEVE UNIVERSAL HEALTH COVERAGE. THE BID INITIATIVE, A COLLABORATION BETWEEN PATH AND THE GOVERNMENTS OF TANZANIA AND ZAMBIA, HAS EMPOWERED COUNTRY GOVERNMENTS TO ENHANCE IMMUNIZATION THROUGH IMPROVED DATA COLLECTION, QUALITY, AND USE. IN 2017, WE CONTINUED TO IMPLEMENT DATA USE AND DATA QUALITY INTERVENTIONS IN BOTH COUNTRIES. THESE INCLUDED ELECTRONIC IMMUNIZATION REGISTRIES, DATA USE CAMPAIGNS, AND OTHER INTERVENTIONS THAT PUT THE POWER OF DATA INTO THE HANDS OF HEALTH WORKERS. THESE TOOLS AND PRACTICES WILL HELP HEALTH WORKERS TRACK AND IMPROVE CHILD IMMUNIZATIONS AND OTHER SERVICES. NONCOMMUNICABLE DISEASES PATH IS AT THE FOREFRONT OF THE FIGHT IN LOW- AND MIDDLE-INCOME COUNTRIES AGAINST NONCOMMUNICABLE DISEASES (NCDS), INCLUDING DIABETES, CARDIOVASCULAR DISEASE, AND WOMEN'S CANCERS. THESE DISEASES ARE RESPONSIBLE FOR TWO-THIRDS OF DEATHS WORLDWIDE, AND ALMOST 75 PERCENT OF THESE DEATHS OCCUR IN LOWER-RESOURCE SETTINGS. IN 2017, PATH CONTINUED TO BUILD THE FOUNDATIONS OF OUR NEW AND EXPANDING NCD PROGRAM. AFTER YEARS OF ADVOCACY AND RELATIONSHIP-BUILDING, PATH WAS SELECTED TO IMPLEMENT A FIRST-OF-ITS-KIND PROGRAM THAT INTEGRATES SCREENING AND CARE FOR HYPERTENSION INTO HIV/AIDS SERVICES IN KENYA. THE PROGRAM WAS IN FULL IMPLEMENTATION IN 2017, WITH 51 PARTICIPATING FACILITIES. PATH ALSO SERVES AS THE SECRETARIAT OF THE COALITION FOR ACCESS TO NCD MEDICINES & PRODUCTS, WHICH WAS LAUNCHED IN 2017. THE GLOBAL, MULTISECTORAL COALITION IS DEDICATED TO INCREASING ACCESS TO ESSENTIAL MEDICINES AND HEALTH PRODUCTS FOR NCDS IN LOW- AND MIDDLE-INCOME COUNTRIES. MEMBERS INCLUDE GOVERNMENT AGENCIES, PRIVATE-SECTOR ENTITIES, NONGOVERNMENTAL ORGANIZATIONS, PHILANTHROPIC FOUNDATIONS, AND ACADEMIC INSTITUTIONS. IN SENEGAL, IN COLLABORATION WITH INTRAHEALTH AND THE MINISTRY OF HEALTH AND SOCIAL ACTION, PATH IMPLEMENTED THE BETTER HEARTS BETTER CITIES PROJECT. THE PROJECT'S AMBITIOUS AIM IS TO IMPROVE THE HYPERTENSION CONTROL RATE IN DAKAR. IN VIETNAM, PATH IMPLEMENTED THE COMMUNITIES FOR HEALTHY HEARTS PROJECT TO IMPROVE BLOOD PRESSURE CONTROL AMONG ADULTS BY INCREASING ACCESS TO AND USE OF HIGH-QUALITY HYPERTENSION SERVICES THAT ARE SUSTAINABLE AND SCALABLE. THE PROJECT DIRECTLY BENEFITS 700,000 PEOPLE IN FOUR DISTRICTS IN HO CHI MINH CITY, AND MORE THAN 300,000 PEOPLE WERE SCREENED IN 2017. PATH CONTINUED TO LEAD AND CONTRIBUTE TO CONVENINGS TO RAISE AWARENESS OF NCDS AND ORCHESTRATE ACTION TO IMPROVE ACCESS TO PREVENTION AND CARE FOR PEOPLE AT RISK FOR OR LIVING WITH THESE DISEASES.
FORM 990, PART III, LINE 4B	HEALTH SYSTEMS INNOVATION AND DELIVERY PATH'S HEALTH SYSTEMS INNOVATION AND DELIVERY PROGRAM IMPROVES THE HEALTH AND WELL-BEING OF PEOPLE IN LOW- AND MIDDLE-INCOME COUNTRIES BY STRENGTHENING HEALTH SYSTEMS AND ENHANCING COUNTRY CAPACITY FOR DATA-DRIVEN DECISION-MAKING. OUR PORTFOLIO SERVES AS AN ORGANIZING MECHANISM FOR PATH PROJECTS, INITIATIVES, AND UNITS THAT STRENGTHEN HEALTH SYSTEMS. THE HEALTH SYSTEMS ANALYTICS (HSA) UNIT PROMOTES SYSTEMS THINKING IN THE DESIGN, IMPLEMENTATION, SCALE, AND EVALUATION OF HEALTH PROGRAMS AND TECHNOLOGIES. WITHIN AND OUTSIDE OF PATH, THIS UNIT LEADS COMPLEX EVALUATIONS, ENGAGES IN IMPLEMENTATION SCIENCE RESEARCH, FACILITATES HEALTH TECHNOLOGY INTRODUCTION, AND WORKS TO IMPROVE DATA QUALITY AND USE FOR DECISION-MAKING. IN 2017, AS PART OF THE GLOBAL FUND'S PROSPECTIVE COUNTRY EVALUATION, THE UNIT BEGAN EVALUATING THE GLOBAL FUND'S BUSINESS MODEL IN THE DRC, GUATEMALA, AND UGANDA USING A MIXED-METHODS APPROACH. THE HSA UNIT ALSO CONCLUDED GAVI FULL-COUNTRY EVALUATIONS IN MOZAMBIQUE, UGANDA, AND ZAMBIA. IN ADDITION, STAFF ENGAGED IN SEVERAL NETWORK ANALYSES TO INFORM THE OPTIMAL STRUCTURE AND FUNCTION OF VARIOUS COALITIONS AND INFORMAL AND FORMAL NETWORKS. WITH THE ACCESS AND DELIVERY PARTNERSHIP, WE CONTINUED TO LAY THE FOUNDATION FOR LOW- AND MIDDLE-INCOME COUNTRIES TO INTEGRATE NEW HEALTH TECHNOLOGIES INTO THEIR HEALTH SYSTEMS, INCLUDING ADDRESSING SUPPLY CHAIN CHALLENGES. WE ALSO ASSISTED THE LEADERSHIP AND MANAGEMENT PROGRAM OF THE WORLD HEALTH ORGANIZATION'S EXPANDED PROGRAM ON IMMUNIZATION BY DEVELOPING CASE STUDIES AND ENSURING MATERIALS WERE APPROPRIATELY TARGETED FOR IMMUNIZATION MANAGERS. FOLLOWING THE WORK OF THE BID INITIATIVE, WE SYNTHESIZED CURRENT IMMUNIZATION DATA LITERATURE AND DISSEMINATED THIS KNOWLEDGE TO KEY DECISION-MAKERS, WHILE FURTHER DISTILLING LESSONS LEARNED REGARDING THE USE OF DATA TO STRENGTHEN IMMUNIZATION SERVICES. PATH FORMED A HEALTH SYSTEMS STRENGTHENING IMPACT TEAM IN 2017 TO BRING TOGETHER EXPERTISE FROM ACROSS THE ORGANIZATION. PLANNED AREAS OF FOCUS INCLUDE STRENGTHENING URBAN HEALTH SYSTEMS, IMPROVING COMMUNITY-LEVEL DATA USE, AND DEVELOPING RESOURCES FOR SUCCESSFUL INTRODUCTION AND SCALE-UP OF INTERVENTIONS AND TECHNOLOGIES. THE GLOBAL HEALTH SECURITY TEAM CONTINUED TO INNOVATE SYSTEMS FOR THE PREVENTION, DETECTION, AND CONTROL OF INFECTIOUS DISEASE OUTBREAKS. WITH THE SUPPORT OF THE US CENTERS FOR DISEASE CONTROL AND PREVENTION, THE TEAM WORKED WITH NATIONAL LEADERS IN SENEGAL, TANZANIA, VIETNAM, AND THE DRC TO STRENGTHEN THEIR PUBLIC HEALTH SYSTEMS AND BUILD THEIR CAPACITY IN EPIDEMIC PREPAREDNESS AND RESPONSE. PATH ALSO CONVENED A CROSS-ORGANIZATIONAL IMPACT TEAM FOCUSING ON EPIDEMIC PREPAREDNESS AND RESPONSE, WHICH HAS BEEN AT THE FOREFRONT OF THE EBOLA RESPONSE IN THE DRC, PROVIDING A KEY ROLE IN SURVEILLANCE, DETECTION, AND RESOURCE MOBILIZATION. PLANNED ACTIVITIES FOR THIS TEAM INCLUDE DEVELOPING AND INTRODUCING INNOVATIONS TO STRENGTHEN ELECTRONIC HEALTH INFORMATION SYSTEMS, ADVANCING NOVEL VACCINE PLATFORMS, PREPARING MEDICAL COUNTERMEASURES FOR PANDEMIC INFLUENZA, AND DEFINING PATH'S ROLE IN COMBATING ANTIMICROBIAL RESISTANCE. NUTRITION INNOVATION RECOGNIZING THAT NUTRITION IS AFFECTED BY A VARIETY OF ECONOMIC AND ENVIRONMENTAL FACTORS, PATH'S NUTRITION INNOVATION INITIATIVE CONTINUED TO DRIVE NOVEL APPROACHES TO ADDRESS THE MASSIVE BURDEN OF MALNUTRITION IN COMMUNITIES AROUND THE WORLD. WE ENGAGED EXPERTS ACROSS THE FIELDS OF GLOBAL HEALTH, DEVELOPMENT, AND THE ENVIRONMENT, FROM BOTH THE PUBLIC AND PRIVATE SECTORS. IN 2017, THE NUTRITION INNOVATION TEAM COMPLETED WORK ON EDIBLE INSECTS IN GHANA WITH ASPIRE FOOD GROUP, HEIFER INTERNATIONAL, THE UNIVERSITY OF GHANA, AND KINTAMPO HEALTH RESEARCH CENTER. WE COMPLETED WORK ON FERMENTED FOODS IN NORTHERN SENEGAL WITH HELITE SARL. THE FINDINGS FROM THESE STUDIES WERE SUMMARIZED IN FOUR SCIENTIFIC PUBLICATIONS. WE CONTINUED TO DRIVE MULTISECTORAL COLLABORATION IN 2017 BY FURTHERING THE BRIDGE COLLABORATIVE, A TRAILBLAZING, CROSS-DISCIPLINARY EFFORT TO ENGAGE MORE THAN 150 LEADING TECHNICAL EXPERTS FROM THE HEALTH, DEVELOPMENT, AND ENVIRONMENTAL SECTORS TO ADDRESS HUMAN AND PLANETARY HEALTH. WE PUBLISHED A MULTIDISCIPLINARY PRACTITIONER'S GUIDE AND A PEER-REVIEWED PAPER, AND WE LAUNCHED A REPORT ON CROSS-SECTORAL COLLABORATION AT A MAJOR GLOBAL EVENT IN LONDON IN OCTOBER 2017. IN INDIA, WE CONTINUED OUR FORTIFIED RICE SCHOOL FEEDING PROGRAM IN KARNATAKA STATE WITH FUNDING FROM THE MARGARET A. CARGILL FOUNDATION. THIS PROGRAM WAS ENDORSED BY THE INDIAN GOVERNMENT AND EXPANDED TO DOUBLE THE NUMBER OF CHILD BENEFICIARIES. WE LAUNCHED A SIMILAR PROGRAM IN GUJARAT WITH SUPPORT FROM THE JAMES PERCY FOUNDATION. IN 2017, THE TEAM LICENSED TWO LOCAL FORTIFIED RICE KERNEL MANUFACTURERS FOR LOCAL PRODUCTION. IN SEATTLE, WE DEVELOPED A SYSTEMATIC REVIEW (EXAMINING THE RELATIONSHIP BETWEEN TOBACCO USE DURING PREGNANCY AND STUNTING) AND A TECHNICAL BRIEF (ON UNDERLYING CONTRIBUTORS TO CHILDHOOD STUNTING) FOR PUBLICATION AND DISSEMINATION. THE NUTRITION INNOVATION TEAM WAS PART OF A NUMBER OF PRESENTATIONS AT INTERNATIONAL FORUMS AND PUBLISHED SEVERAL GROUNDBREAKING STUDIES, ADVANCING INNOVATIVE THINKING ON BROAD, EFFECTIVE SOLUTIONS.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CHIEF FINANCIAL OFFICER SIGNED AND FILED THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12C	PATH HAS POLICIES AND PROCEDURES TO ADDRESS CONFLICTS OF INTEREST. PATH MANAGEMENT AND ALL STAFF AT A DESIGNATED LEVEL OR HIGHER WITHIN THE ORGANIZATION MUST ANNUALLY COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND, IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER. THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING.
FORM 990, PART VI, SECTION B, LINE 15	THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARIES AND BENEFITS FOR EXECUTIVE EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE PRESIDENT/CHIEF EXECUTIVE OFFICER (CEO) ON COMPENSATION DECISIONS FOR EXECUTIVE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT/CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS). THE LAST MAJOR REVIEW WAS COMPLETED BY THE BOARD COMPENSATION COMMITTEE IN 2017. AT THE REQUEST OF THE BOARD, PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE USE OF THE REPORT TO ESTABLISH A FRAMEWORK WITHIN WHICH THE PRESIDENT/CEO IS DELEGATED AUTHORITY TO ESTABLISH THE TOTAL COMPENSATION PACKAGES OF THE VICE PRESIDENTS AND EXECUTIVE TEAM MEMBERS. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFITS PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S TOTAL COMPENSATION PACKAGE.
FORM 990, PART VI, SECTION C, LINE 19	PATH GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.
FORM 990, PART XI, LINE 9:	FROM TIME TO TIME, UNSPENT AWARD FUNDS (OR UNUSED OBLIGATIONS) MAY BE RETURNED TO A FUNDER FOR A VARIETY OF REASONS INCLUDING, BUT NOT LIMITED TO, EARLY TERMINATION OF A PROJECT BY A FUNDER OR A REDUCTION IN FUNDS REQUIRED TO ACCOMPLISH A PROJECT'S SCOPE OF WORK. -7,056,439.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd	Address Line1ForeignAddress/AddressLine1Txt	CityForeignAddress/CityNm	CountryForeignAddress/CountryCd	Legal Domicile Foreign CountryLegalDomicileForeignCountryCd
PATH VACCINE SOLUTIONS
2201 WESTLAKE AVENUE	SEATTLE	WA	98109	830431851	ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN	WA	501(C)(3)	LINE 12A, I	PATH	Yes (1)
PATH DRUG SOLUTIONS
280 UTAH AVENUE SUITE 250	SAN FRANCISCO	CA	94080	943384500	DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES	CA	501(C)(3)	LINE 12A, I	PATH	Yes (1)
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
					EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH		501(C)(3)		PATH	Yes (1)	207 ROUTE DE FERNEY 1218 LE GRAND-S	GENEVA	SZ	SZ

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (1)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (1)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	0	SharingOfFacilitiesInd
Paid Employees Sharing	0	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (5 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
PATH VACCINE SOLUTIONS
C	$15,312,358	FMV
PATH DRUG SOLUTIONS
C	$1,884,329	FMV
PATH DRUG SOLUTIONS
B	$146,405	FMV
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
C	$2,200,910	FMV
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
B	$4,757,783	FMV